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ABSTRACT 
The salivary proteome is recognized as a valuable source of potential oral and 
systemic disease biomarkers. Major efforts in salivary research have been dedicated to 
identify and characterize salivary proteins present in saliva using both classical 
biochemical methods and proteomics approaches in adults. Despite considerable 
research on the salivary proteome, little attention has been given to the changes in the 
salivary proteome occurring in children, specifically from 0-3 years of age. Through the 
use of anionic PAGE, SDS PAGE, HPLC and MS/MS, salivary protein profiles in 
children before, during and after dental eruption were compared with edentulous adult 
controls. We identified substantive qualitative and quantitative differences in the salivary 
proteome between children and adults, suggesting a greater emphasis is warranted in 
the study of the changes in the salivary proteome as a function of age and dental status.  
 
KEY WORDS 
Saliva, dental eruption, edentulous adults, salivary proteins, proteomics,  
protein quantification, anionic PAGE, SDS-PAGE, HPLC, mass spectrometry.
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When you sense a thirst for knowledge, 
 why not  
perform mouthwatering research? 
 
When you feel the answer on the tip of your tongue, 
why not  
start by looking there? 
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1.1 Introduction to saliva 
 
Saliva is indispensible in the maintenance of health and homeostasis in the body. 
The critical importance of saliva is strikingly evident in individuals with reduced salivary 
flow who experience: tooth decay/loss, acute irritation of oral mucosa, and severe 
difficulties with airflow, speaking, swallowing, food clearance and taste. Saliva’s utility 
extends still further, far beyond the oral cavity, with the discovery of oral and systemic 
disease biomarkers in saliva. The use of salivary biomarkers as diagnostic tools must 
be preceded by a clear understanding of salivary biochemistry in different conditions 
and throughout the stages of life.  
Saliva is defined as the mixture of fluid, organic, and inorganic components 
derived in large part from salivary gland secretions, the gingival fold, oral mucosa, 
desquamated epithelial cells, blood cells, food, and microorganisms (1-7). The complex 
composition of saliva reflects the dynamic equilibrium that exists between host, external 
forces and microbial flora present in the oral cavity (8). The large inter- and intra-
individual variation present in the salivary biochemical composition throughout the life 
stages poses both a challenge to understanding saliva’s biochemical properties, but 
also a tremendous opportunity to uncover stage-specific biological data potentially 
relevant in the clinical setting (9-12). 
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From a biochemical perspective, it is recognized that proteins in saliva represent 
a rich source of relevant biological information (6). Great effort has been dedicated to 
identifying the proteins present in adult saliva (4, 7, 13-25). Despite the magnitude of 
research devoted to salivary proteomic research, few have studied the salivary 
proteome in children (26-29). In order to address this deficit and develop a deeper 
understanding of the salivary proteome at different life stages, this thesis is focused on 
the protein profile of saliva in children as their primary dentition erupts, from the ages of 
0 to 3 years.  
1.2 Overview of the salivary glands 
Salivary glands are responsible for producing and actively secreting protein-
containing fluid into the oral cavity. These secretions represent an important contribution 
to whole saliva (30, 31). Salivary glands are classified into two categories: major and 
minor (30).  
The major salivary glands contribute approximately 90% of the fluid present in 
whole saliva. The three paired major salivary glands are: the parotid, submandibular, 
and sublingual glands (30). The minor salivary glands supply approximately 10% of the 
fluid present in whole saliva. There are an estimated 400-600 minor salivary glands in 
the oral cavity. They are located in the mucosa of most of the soft tissue surfaces in the 
mouth, including the cheeks, lips, palate and tongue (lingual/Von Ebner glands) (6, 31, 
32). 
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1.2.1 Salivary gland anatomy 
The parotid gland, the largest of the major salivary glands, is located near the 
mandibular ramus and provides mainly serous fluids through the Stenson’s duct that 
opens into the oral environment near the second upper molars. The submandibular 
gland is located near the lower jaw bone and provides mostly serous fluids through the 
Wharton’s duct that opens to the oral environment near the junction of the tongue and 
the floor of the mouth. The sublingual gland is located near the submandibular gland 
and provides mainly mucous fluids through the Bartholin’s duct that opens to the oral 
environment near the junction of the tongue and the floor of the mouth in close 
association with the Wharton’s duct. A schematic illustrating the anatomy of the major 
salivary glands and the associated ducts is found in Figure 1.1. 
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Figure 1.1 – Anatomy of the major salivary gland and associated ducts. This schematic depicts 
the location and form of the major salivary glands (parotid, submandibular and sublingual) and 
the corresponding ducts (Stenson’s, Wharton’s, and Bartholin’s) through which glandular saliva 
is introduced into the oral cavity. 
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1.2.2 Salivary gland histology 
Salivary glands contain two types of epithelial cells: Ductal and Acinar. Ductal 
cells are primarily involved in establishing the ionic composition of the glandular 
secretions. Ductal cells alter the electrolyte content of the fluid originating from the 
acinar cells primarily by reabsorbing sodium chloride (33, 34). Ductal cells also secrete 
proteins, although far fewer than acinar cells (34). Acinar cells make up the acini, the 
secretory endpiece of the salivary gland ductal trees.  Acinar cells function by 
synthesizing and secreting the majority of the functionally significant host-derived 
salivary proteins, as well as actively transporting water and electrolytes (31).  
Acinar cells are classified into two categories: Serous and mucous. The type of 
secretion produced by a gland is determined by the ratio of serous to mucous acinar 
cells (6, 31). Serous acinar cells secrete a proteinaceous, watery fluid, largely lacking 
mucus. They are present in the parotid, submandibular, palatal, and lingual glands. 
Mucous acinar cells secrete a mucous-rich substance, with high viscosity and elasticity. 
They are present in the submandibular, sublingual, labial, palatal, and lingual glands (6). 
1.3 Regulation of salivary secretion 
Health and homeostasis of the oral environment depends greatly on the 
presence of saliva and its protein composition. In order to maintain this vital role, 
salivary flow is under the control of both the parasympathetic and sympathetic branches 
of the autonomic nervous system (31). Both branches positively regulate flow from 
salivary glands (35). The type of stimulation determines the ratio of activation between 
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the two branches of autonomic control. In healthy individuals, resting or ‘unstimulated’ 
salivary flow rate is approximately 0.4 mL/min with a standard deviation of 0.21 mL/min. 
In contrast, ‘stimulated’ salivary flow rate is approximately 1.6 mL/min with a standard 
deviation of 2.1 mL/min. It is important to note the high standard deviations in both the 
‘unstimulated’ and ‘stimulated’ saliva, as this reflects the wide range of normal healthy 
values in salivary secretion (3). 
Parasympathetic control of salivary secretion 
Parasympathetic innervation is responsible for initiating salivary secretion and 
maintaining high secretion rates (35). Cholinergic parasympathetic nerves innervate all 
salivary glands. Parasympathetic stimulation of muscarinic cholinergic and alpha-
adrenergic receptors on the parotid salivary glands leads to a high flow rate of a fluid 
containing low protein and high ion concentrations. Parasympathetic stimulation can be 
sustained over long periods and accounts for the majority of salivation control. Baseline 
amounts of salivary fluid and protein secretion are maintained at a ‘resting’ or 
‘unstimulated’ rate in the absence of appropriate stimuli. (31).  
Sympathetic control of salivary secretion 
Sympathetic nerves are unable to initiate or maintain secretions independently. 
Rather, these nerves potentiate parasympathetic effects through the release of 
noradrenaline targeted at stimulating alpha- and beta-adrenergic receptors on acinar 
and ductal cells to induce the release of stored proteins (31, 35). The presence of 
stimuli (i.e. mastication) leads to a drastic increase in salivary flow, up to ten fold, 
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signaled by sympathetic stimulation. Sympathetic stimulation is short-lived, releasing 
large amounts of digestive enzymes and macromolecules such as mucin, which help 
lubricate and protect soft tissues in the oral cavity. Sympathetic stimulation of 
submandibular and sublingual glands results in a low flow rate of fluid containing a high 
protein concentration (34).  
Salivary protein secretion 
Protein secretion is initiated by the binding of neurotransmitters to the 
appropriate receptors on the basolateral membrane of acini secretory cells. The chief 
neurotransmitter released by parasympathetic nerves is acetylcholine. Noradrenaline is 
the primary neurotransmitter released by sympathetic nerves. Once bound, the 
neurotransmitters signal the induction of downstream intracellular mechanisms, 
beginning with second messengers and terminating in the release of salivary proteins 
out of the acinar secretory vesicles and into the acinar lumen. The majority of salivary 
gland protein excretion results from the exocytosis of protein storage granules in acinar 
cells (31). The type of stimuli, including environmental and physiological factors, such 
as: chemical or mechanical stimulation, psychological stress, pathological conditions 
and pharmacological stimuli, alters the protein profile of the secretions (36). It is for this 
reason that great attention is given to the types of stimuli enlisted for the collection of 
saliva samples destined for analysis. In this study, to account for the variation in the 
protein profile of the secretions caused by the factors listed above, samples were 
carefully collected from individauls in the absense of chemical or mechanical stimulation 
(unstimulated whole saliva). All individuals were maintained in a restful state before and 
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during collection. Individuals must have met the inclusion criteria of being in a state of 
good health and free of medications.  These careful considerations helped to enable 
appropriate comparisons between different age groups. 
1.4 Composition of whole saliva 
Since the beginning of salivary research in the early 20th century, saliva has been 
recognized as a complex fluid. It has been stated that saliva is more appropriately 
regarded as a fluid tissue than a solution (37).  
Whole saliva originates from major (parotid, submandibular, sublingual) and 
minor salivary gland secretions, as well as serum filtrate components (gingival 
crevicular fluid), host cells derived from tissues throughout the oral cavity (desquamated 
cells from the oral epithelium), microorganisms and microbial products (2, 5), blood and 
serum products from wounds, nasal and bronchial secretions (19, 38-40), and food 
debris (30). Plasma proteins are also present in saliva and are introduced through 
several avenues. Passive diffusion, ultrafiltration (evident at tight cellular junctions) and 
the contributions of serum transudate originating at the gingival sulcus referred to as 
gingival crevicular fluid (GCF), are the most common modes of entry for plasma 
proteins into saliva. 
Water constitutes approximately 99.5% of the total volume of whole saliva (6, 7). 
Proteins account for an estimated 0.3% of the total volume of whole saliva (6). Inorganic 
and trace substances (i.e. electrolytes, sugars, lipids, hormones and nitrogenous 
products) comprise the remaining 0.2% of whole saliva’s total volume. Inorganic and 
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trace substances, while relatively low in concentrations, are critical to saliva’s function in 
the maintenance of oral health. Unstimulated saliva has an average pH range of 5.7-
7.1, while stimulated saliva is known to have a pH of up to 7.8 (3). 
Electrolytes present in saliva include: sodium, potassium, calcium, chloride, 
magnesium and bicarbonate. These common electrolytes are present in final 
concentrations that deem saliva hypotonic to other body fluids. Nitrogenous products, 
such as urea and ammonia, are also present in saliva (1, 6, 7, 41). 
Saliva contains an estimated 700 species of microorganisms (42). 
Microorganisms contribute an assortment of enzymes to saliva’s composition (43). 
Proteolytic enzymes, from multiple sources (i.e. bacterial, burst leucocytes), cleave a 
great number of salivary proteins into peptides. The extensive proteolysis and 
deglycosylation evident in saliva is another important consideration for salivary 
research. Some proteins may be granted protection from proteolytic cleavage if bound 
to hydroxyapatite, the primary constituent of tooth enamel. Histatin 1 is a good example 
of a protein that avoids proteolytic cleavage by binding to the tooth surface (44). 
Host-derived proteins present in saliva are commonly divided into structurally 
related groups, referred to as salivary protein families. The major salivary protein 
families are described in the next section.  
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1.5 Salivary protein families 
The eight major salivary protein families are: Amylases, Histatins, Mucins, 
Statherins, Cystatins, Carbonic Anhydrases, Peroxidases, and Proline-rich proteins.  
Table 1.1 summarizes the primary protein source, chief known function, molecular 
weight, modifications/isoforms if present, and concentration measured in whole saliva. It 
is important to note that concentrations of salivary proteins vary, and the numbers 
provided are mean values or ranges measured in resting whole saliva in adults.  
  
 
 
 
 
Table 1.1 - Summary of Protein Families found in Saliva. The source, function, molecular weight, modification/isoforms and 
concentration in whole saliva for the eight major protein families (Amylase, Histatins, Mucins, Statherins, Cystatins, Carbonic 
Anhydrases, Peroxidases, and Proline-rich Proteins) are highlighted in this table. 
 
  
Protein Source Function MW Modifications/Isoforms Conc. in whole 
saliva 
Amylase  
(17, 22, 
45-47) 
Chiefly the 
parotid gland 
Digestion – Hydrolyzes starches (i.e. amylose, 
amylopectin, maltose, glucose) by catalyzing hydrolysis 
of alpha 1-4 glycosidic linkages in starch. 
Protection – Selective binding of oral microorganisms 
(i.e. S. gordonii, S. minits, S. oralis), preventing bacterial 
attachment and aiding bacterial clearance. 
53-57 kDa Glycosylated and 
unglycosylated isoforms 
present  
 
380-500 
µg/mL 
Histatins  
(17, 48-
50) 
Major salivary 
glands (parotid, 
submandibular
and sublingual) 
and minor 
salivary glands 
(sublingual) 
Short distinct functional domains determine histains’ 
biological functions. 
Anti-fungal: Kills C. albicans (in both yeast and mycelial 
form) through the proposed mechanism of taking on a 
helical structure that disturbs cell membranes. Histatins 
are also potent C. albicans growth inhibitors 
Anti-bacterial: Inhibits the trypsin-like activity of P. 
gingivalis (gram negative bacteria associated with forms 
of periodontal disease). Does not inhibit host trypsin or 
chymotrypsin activity. Inhibits bacterial-induced 
hemagglutination, and bacterial colonization. 
Histatins also bind hydroxyapatite, complex with metal 
ions, inhibit crystal growth of calcium phosphate salts 
and stimulate wound-closure 
Histatin 1  - protects tooth enamel and pellicle formation 
(typical of phosphorylated salivary proteins) 
Histain 5 – most potent candidacidal property amongst 
histatins 
3-6 kDa  Histatins exist in 3 major 
isoforms (Histatin 1, 3, and 5) 
Histain 1, the only 
phosphorylated isoform, is 
phosphorylated on serine 2 
Major forms of histatin 
undergo proteolytic cleavage 
to form minor forms of histatin 
2-8 µg/mL 
Mucins   (1, 
7, 17, 51-
56) 
Submandibular, 
sublingual 
glands 
Primarily 
sublingual and 
minor mucous 
glands 
Provides salivary viscoelasticity and lubrication. 
Protection – physical barrier from bacterial protease 
activity, helps regulate bacterial and fungal colonization 
by selectively modulating adhesion of microorganisms to 
oral tissue surface, lubrication, preventing desiccation 
Concentrates anti-microbial salivary components to 
mucosal interface 
Helps form acquired enamel pellicle 
120-1000 
kDa 
(Glycosylaton 
account for 
40-80% of 
mass) 
Two structurally distinct 
species of mucins secreted 
by salivary glands – MG1 
(oligomeric) and MG2 
(monomeric) 
Glycosylation –high 
carbohydrate content largely 
on serine and threonine 
residues 
10-500 µg/mL 
Statherins  
(17, 55) 
Produced by 
acinar cells 
Inhibits crystal growth of calcium phosphate salts 
Inhibit the spontaneous precipitation of calcium 
phosphate salts from the supersaturated concentrations 
present in saliva. 
Binds bacteria 
Binds with high selectivity and great affinity to 
hydroxyapatite 
5380 Da Phosphoproteins rich in 
tyrosine, glutamine, and 
proline 
2-12 µg/mL 
  
Cystatins  
(17, 55) 
Isolated from 
submandibular 
secretions 
Bind hydroxyapatite (3 times weaker than statherin) 
Inhibit crystal growth of calcium phosphate salts (10 
times weaker than statherin) 
14 kDa SN, S, and S1 isoforms. Exist 
in phosphorylated and 
unphosphorylated forms.  
240-280 
µg/mL 
Carbonic 
Anhydrases  
(17, 57)  
Submandibular 
and parotid 
glands 
Protection – involved in salivary pH regulation 
Low salivary concentrations of CA-VI are associated 
with increased prevalence of caries 
42 kDa  7 isozymes and several 
homologous carbonic 
anhydrase-related proteins 
Can be glycosylated 
4.6 µg/mL  
 
Peroxidases  
(58-61) 
GCF and 
neutrophil 
granulocytes 
(Myeloperoxi-
dase), Salivary 
glands 
(Lactoperoxi-
dase) 
Anti-bacterial action –Involved in the intracellular 
metabolism of H2O2 leading to production of 
hypothiocyanite (OSCN-) an even more effective 
bactericidal and fungicidal agent. Helps prevent 
decalcification of enamel caused by bacterial acid 
production resulting from carbohydrate fermentation. 
78-280 kDa 2 major forms found in saliva 
- Myeloperoxidase and 
Lactoperoxidase 
1-5 µg/mL 
Proline-rich 
protieins  
(43, 55, 
62) 
 Solubilize calcium phosphate to inhibit crystal growth. 
Remineralization – in the early and late acquired enamel 
pellicle through the binding of hydroxyapatite (acidic 
PRPs). 
Caries prevention – a subset of basic PRPs differs in 
individuals with resistance to caries formation. 
 PRPs  are classified as 
acidic, basic and glycosylated 
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1.6 Functions of saliva 
Saliva plays important roles in the mouth and upper portion of the gastrointestinal 
tract that are critical for preserving health and homeostasis in the body. Saliva’s 
functions, related to its fluid characteristics and composition, can be classified in the 
following 5 broad categories:  Protection/maintenance of teeth and oral mucosa, 
digestion, swallowing/clearance, airflow/speech, and taste. 
1.6.1 Protection and maintenance of teeth and oral mucosa 
Protection through lubrication  
Lubrication, defined as the ability of a substance to decrease friction between 
moving surfaces, is regarded as one of the most vital functions of saliva. Saliva 
lubricates the mucosa and helps protect against irritation (i.e. mechanical, thermal, and 
chemical) (7, 30, 31). The importance of appropriate lubrication is readily observed in 
the effects of abrasive wear of epithelial surfaces and the destruction of tooth tissue 
when sufficient lubrication is not present (6). Lubrication has been associated with 
several salivary proteins, including: mucins  (53, 63), statherin  (63, 64), amylase  (65), 
proline-rich glycoproteins  (3, 66), and acidic proline-rich proteins  (63). 
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Protection through immunological defense 
Saliva is the first line of oral immune defense  (67). The immunological defense 
provided by saliva is of great importance, as the oral cavity serves as the entry point of 
a wide range of substances into the alimentary track. This first line of defense protects 
through anti-bacterial, anti-fungal and anti-viral functions. Anti-bacterial functions 
include specific (i.e. secretory immunoglobulin A) and non-specific mechanisms (i.e. 
lysozyme, lactoferrin, myeloperoxidase, cystatins, histatins, Von Ebner’s gland protein 
(VEGh), secretory leukocyte protease inhibitor (SLPI), calprotectin, lactoperoxidase, 
chromogranin A). Anti-fungal and anti-viral properties are similarly achieved with a 
combination of specific (i.e. secretory immunoglobulin) and non-specific components 
(anti-fungal: histatins, chromogranin A; antiviral: cystatins, mucins, SLPI). Mechanical 
cleansing of bacteria and the dilution of detrius add to the immunological protective 
functions of saliva.  
Protection through buffering 
Buffering and acid neutralization from oral and gastric sources is also conferred 
by saliva’s composition, namely: bicarbonate, phosphate, and the negatively charged 
residues in salivary proteins. The neutralization of acids produced by acidogenic 
microorganisms offers teeth protection by preventing enamel demineralization (30). The 
salivary peptide, sialin, is a good example of saliva’s buffering activity. Sialin increases 
the pH on the tooth surface and releases ammonia and carbon dioxide after undergoing 
hydrolysis by bacterial ureases (3, 41). The carbonic acid-bicarbonate system serves as 
an excellent example of an important pH buffer in stimulated saliva and phosphate 
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buffer in unstimulated saliva (3). In saliva, hydronium and bicaronate ions combine to 
form carbonic acid. Carbonic anhydrase functions to regulate pH by facilitating the 
conversion of carbonic acid into water and carbon dioxide. Through the actions of 
bicarbonate ions working in concert with carbonic anhydrase, the pH is effectively 
increased through the net eilmation of hydronium and bicarbonate ions and production 
of water and carbon dioxide. 
Maintenance of teeth and oral mucosa 
Saliva occupies a vital role in maintaining the physical-chemical integrity of tooth 
enamel. In addition to lubrication of the hard and soft tissues and buffering capacity of 
saliva, the maintenance of the integrity of teeth and oral mucosa is achieved through 
saliva’s ability to protect against demineralization (mucins, Ca2+, phosphate), and 
recuperate mineral loss through remineralization (PRPs, statherin, Ca2+, phosphate) 
(31). 
The stability of tooth enamel’s hydroxyapatite composition is controlled by 
salivary pH and concentrations of free calcium, phosphate and fluoride. The 
supersaturated calcium phosphate concentration, with respect to hydroxyapatite, leads 
to the formation and maintenance of the protective pellicle present on the enamel 
surface. Maintaining the equilibrium between calcium phosphate demineralization and 
remineraliztion is a critical function of salivary proteins  (55). 
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1.6.2 Digestion 
Saliva is also responsible for the initiation of starch and lipid digestion. Digestive 
enzymes, such as alpha-amylase, cleave starches into maltose, maltotriose, and 
dextrins, contributing to the digestive process (30). 
1.6.3 Swallowing/Clearance 
Saliva dilutes and mechanically cleanses non-adherent particles (i.e. bacteria, 
cellular, and food detritus), aiding in their clearance from the oral cavity. As an added 
benefit, the clearance of food detritus, in particular excess carbohydrates, results in a 
reduction of the availability of sugar for microorganism metabolism (7). Food bolus 
formation aiding swallowing is also helped by the presence of saliva (30). By extension, 
the clearing capabilities of saliva are not limited to the oral cavity, as it also aids 
esophageal clearance.   
1.6.4 Airflow/Speech 
The fluid properties of saliva are critical to facilitate airflow and enhance speech 
quality. The importance of this function is most evident in instances with reduced 
salivary flow. 
1.6.5 Taste 
By serving as a solvent, saliva also facilitates taste by aiding in dissolving taste 
compounds and enhancing interaction of food products with taste buds (30). While the 
salivary fluid in acini starts isotonic to plasma, as it travels through the duct network it 
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becomes hypotonic in glucose, sodium, chloride and urea concentrations (3, 34). This 
aids in the perception of dissolved substances by gustatory buds.  
1.6.6 Conclusion to functions of saliva 
With such vital functions, saliva is of monumental importance in the maintenance 
of teeth, oral mucosa and overall oral health (3).  While the functions of a great number 
of proteins and peptides contained in saliva are not yet well understood, it is clear there 
is a great deal of redundancy in salivary composition for it to be able to accomplish 
these functions and uphold the integrity of the teeth and oral mucosa with the required 
ecological balance (3, 31). 
1.7 Current Knowledge of the salivary proteome 
Proteomic studies centered on identifying the salivary proteome have increased 
dramatically in the past decade. The investigation of proteins on a large scale draws 
upon an ever-improving toolbox of techniques  (13, 24, 28, 68-77).  
During the past decade, more than 3000 different proteins have been identified in 
saliva (15, 18, 24, 25, 75, 78, 79). In 2010, Loo and colleagues from the University of 
California-Los Angeles compiled recent data from multiple laboratories to form a list of 
2290 proteins present in whole saliva  (72). Most recently, the same laboratory identified 
1,166 proteins as the core salivary proteome (80). This compiled data set was consulted 
during the analysis of proteins in this study. The ongoing fluctuation in the size of the 
salivary proteome catalogue is closely related to the challenges present in the analysis 
and categorization of salivary proteins. One of those challenges is the great number of 
structurally related proteins found in saliva. The abundance of structurally related 
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proteins is commonly shared with other proteomes, most notably in blood, and has 
important implications with the application of mass spectrometric-based methods for the 
identification of proteins. Protein identification with MS/MS relies on sequencing 
peptides unique to a protein. If a sequenced peptide is common between a number of 
proteins, the accurate identification of the parent protein becomes more difficult. To 
address this, a variety of proteomic tools are often enlisted to accurately distinguish 
unique protein species.  
The critical stage of any study examining proteins in a complex mixture is protein 
separation. A wide variety of protein separation techniques have been applied to the 
study of salivary proteins. Gel electrophoresis and liquid chromatography are two of the 
most powerful protein separation techniques applied in salivary studies.  
Both 1- and 2-dimensional PAGE (1D- and 2D-PAGE) are effective methods of 
protein separation and have been widely used to separate salivary proteins  (4, 6, 14, 
29, 81). Both methods provide visuals of profiles of protein mixtures that can be used to 
assess variability between samples, people, and groups. 2D-PAGE is a powerful 
technique of protein separation but harbors significant limitations that remain highly 
relevant in salivary protein research. 2D-PAGE is ill suited for the detection of small MW 
proteins, highly acidic or basic proteins, highly hydrophobic proteins, as well as proteins 
in low abundance (6). The presence of many small MW proteins and peptides, as well 
as a significant number of highly acidic, basic, hydrophobic and proteins present in very 
low concentrations in saliva, invites alternative methods of protein separation, such as 
liquid chromatography.  
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1.8 Purpose of thesis 
 
With a great impetus to realize the tremendous translational potential of saliva as 
a diagnostic resource, the focus must now be concentrated on developing and 
understanding the basic biochemistry of saliva at all stages of life. The successful and 
meaningful analysis of salivary proteins necessitates optimized methods of collection, 
processing and storage conditions (82).  
Until now, the majority of proteomic studies have focused on adult populations, 
with very little attention given to characterizing the salivary proteome in children. 
Clinically, it is known that children and adults differ in an array of biological parameters 
used to assess health status via monitoring and diagnostic tools. Saliva, as well as 
blood, have both been shown to harbour clinically relevant age-dependent differences. 
While the focus of this study is not centered around gender, race, or environtmentally-
related differences, these are also factors that warrant continued attention as they may 
provide further valuable biological insights. It is imperative to understand the standard 
baseline of the salivary protein profile, and how it changes with age, among other 
factors, in order to establish appropriate comparisons between individuals at different 
states of health. 
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With this knowledge, the purpose of this thesis is centered on the following two 
central aims: 
1. To establish and optimize techniques for the analysis of the salivary proteome in 
children, as well as adults. Establishing techniques and optimizing methods is a crucial 
step in the successful and meaningful analysis of salivary samples. 
2. To identify qualitative and quantitative changes in salivary protein profiles as primary 
dental eruption events unfold in children from the ages of 0 to 3 years. 
1.9  Hypothesis 
We hypothesize that there are observable qualitative and quantitative changes in 
the salivary protein profile throughout the course of dental eruption, in children from age 
0 to 3 years. 
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Chapter 2 – Changes in the salivary proteome during the course of dental 
eruption 
2  
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2.1 Experimental Design Overview 
2.1.1 Sample Collection 
The eligibility of individuals to donate unstimulated whole saliva for this study was 
based on the following inclusion criteria. The individual must be deemed healthy 
according to their medical history, and therefore free of any acute or chronic medical 
conditions (i.e. Asthma, diabetes, renal or cardiac conditions). At the time of sampling, 
the individual must be included in one of the following four categories: 
Children with no teeth – Absence of primary dentition 
Children with 1-19 primary teeth – Partial primary dentition 
Children with 20 primary teeth – Complete primary dentition 
Adults with 0 permanent teeth – Complete denture patients 
 
 Samples were rejected from this study if any of the “Exclusion Criteria” in Table 
2.2 were met. Individuals must not be taking any medication to avoid potential drug-
related effects on salivary flow and/or composition. Collection of unstimulated whole 
saliva from individuals meeting the “Inclusion Criteria” listed in Table 2.2 was sampled in 
the described manner.  
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Table 2.1 - Summary of group categories. Groups A, B, and C represent children participants pre-, 
during, and post-dental eruption, respectively. The age ranges described in the table for Groups 
A, B, and C, serve only as guidelines. Samples from children were grouped according to the 
number of teeth present at the time of collection. Group D represents the edentulous adult 
controls.  
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  Group   
No. of 
Teeth Description 
Children A Pre-dental eruption 0 Children approx. 0-6 months old* 
 B During dental eruption 1-19 Children approx. 7-24 months old* 
 C Post-dental eruption 20 Children approx. 25-36 months old* 
Adults D No dentition (edentulous) 0 Adults <65 years of age with complete dentures 
*Age categories serve only as guidelines indicating the stage of dental eruption. Samples were classified strictly based on the 
number of teeth full and partially erupted at time of collection. 
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Table 2.2 - Criteria used in the selection of individuals to donate saliva. All individuals included in 
this study were required to meet the inclusion criteria. Salivary samples were excluded from the 
analysis if any of the exclusion criteria were met. 
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Inclusion Criteria Exclusion Criteria 
Healthy – including their medical history  Presence of any chronic or acute medical conditions 
Children approx. 36 months or younger Consumption of any food or water within 1 hour prior to collection 
OR If individual became stressed during collection 
Edentulous adults 65 years or younger 
Any medications (as they may interfere with salivary secretion and 
composition) 
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All saliva samples were collected between the hours of 10:00 AM and 12:00 PM, 
to minimize any inter-individual variation of saliva composition associated with circadian 
rhythms (83). Unstimulated whole saliva was aspirated using a portable suction device 
and disposable mouthpiece attached to a 1.5 mL eppendorf snap cap tube, as depicted 
in the schematic in Figure 2.1. To prevent proteolytic degradation of salivary proteins, 
collection tubes remained on ice at all times during collection. To achieve an accurate 
assessment of resting, unstimulated whole saliva, great care was put forth during 
collection to ensure the individual was seated comfortably while collection took place.  
Sample was discarded if subject became stressed or if child began to cry. Upon 
completion of sample collection, all samples were stored at – 40°C. 
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Figure 2.1 - Schematic of suction device adapted for collection of unstimulated whole saliva 
samples. The portable suction device, shown on the left of the schematic, produced a gently 
powered suction that was connected to the eppendorf snap cap lid with a needle adaptor. A 
second needle adaptor attached to a disposable mouthpiece and tubing was inserted to the same 
eppendorf snap cap tube, as depicted in the figure. This set up resulted in a disposable 
mouthpiece terminal with gentle but effective suction, well suited to collect whole saliva from 
children and adults. All collection tubes remained on ice during the collection process. 
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2.1.2 Patient Demographics 
34 
 
 
 
 
 
 
 
 
 
 
 
Table 2.3- A summary of the unstimulated whole saliva samples collected for this study. The 
following patient demographic parameters from all four groups, Group A (Pre-dental eruption), 
Group B (During dental eruption), Group C (Post-dental eruption), and Group D (Adult controls) 
are summarized: Age, sex, volume of unstimulated whole saliva collected, and number of teeth 
present.
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2.1.3 Project Experimental Design 
The goal of this study was to examine and compare the salivary proteome in 
children during the course of dental eruption in children and edentulous adult controls. 
Hence, children were divided into three cohorts (pre-, during, and post-dental eruption) 
and adult controls grouped into a fourth cohort. Samples were analysed individually, as 
well as pooled in each cohort, to assess both inter-individual and inter-group 
differences. The overall design of the experimental approach used in the analysis is 
shown in Figure 2.2. The scheme describes the analysis flow for all samples. 
Whole saliva samples were centrifuged and the supernatants collected. The 
supernatants were then quantified for total protein concentration. The supernatants 
were then used to complete the three major avenues of analysis seen in Figure 2.2, 
PAGE, HPLC and MS. Separation of proteins based on molecular weight, negative and 
positive charge was achieved using PAGE. The minimal protein requirement for PAGE 
analysis permitted the analysis of pooled cohort samples in both gel types (SDS and 
anionic) and individual samples to be examined with both SDS and anionic PAGE. 
Separation as a function of the degree of protein hydrophobicity was realized through 
the use of reverse phase HPLC. Protein identification was attained through mass 
spectrometric analysis. Processing and analysis of all whole saliva samples used in this 
study was completed according to the following methodologies.     
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Figure 2.2 - The overall experimental design for the analysis of unstimulated whole saliva 
samples. The first stage of the experimental design involved recruiting children pre-, during, and 
post-dental eruption (Groups A, B, and C, respectively), as well as edentulous adult controls 
(Group D) to participate in the study. Saliva sample collection was followed by total protein 
quantification. The samples were then analyzed first with PAGE, followed by HPLC, and then LC-
MS, as described in the methods. 
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2.2 Materials and method 
Due to the mixture of components present in whole saliva, in particular proteolytic 
enzymes and mucins, precautions are taken and all procedures adhered to with respect 
to sample collection, processing prior to analysis, sample storage and treatment, to 
ensure the successful preservation and analysis of all samples. 
2.2.1 Unstimulated whole saliva collection 
All samples were collected from study participants with full consent and approval 
(See APPENDIX 2 for General Letter of Information and Consent). The collection 
protocol was approved by the Health Sciences Research Ethics Board (HSREB) at 
Western. Parents or Legal Guardians were consulted for sample collection from child 
participants. All sampling was conducted between a two-hour period (10:00 AM and 
12:00 PM) to minimize inter-individual variation of saliva composition associated with 
circadian rhythms  (83). To ensure true resting and unstimulated saliva samples, 
participants did not consume any food or water for a full hour prior to collection. All 
participants were relaxed and seated upright throughout collection. At the first signs of 
distress, most relevant for the youngest volunteers, collection was stopped and samples 
discarded. This procedure ensured all samples reflected resting unstimulated whole 
saliva. Samples were collected with a sterile disposable mouthpiece connected to a 1.5 
mL polypropylene microtube. A portable suction device was used to create a gentle 
suction in the tube to facilitate saliva collection. See Figure 2.1 for an illustration of the 
set-up successfully adapted for the collection of unstimulated whole saliva. Throughout 
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sampling, collection tubes were stored on ice to inhibit proteolytic degradation of 
salivary proteins outside the oral cavity. 
2.2.2 Pre-analysis sample processing 
Immediately after collection saliva samples were centrifuged at 14 000 rpm for 20 min at 
4°C. The supernatants were gently aspirated with a 200 µL pipette to avoid disturbing 
the pellet. The supernatants were aliquoted into microfuge tubes and frozen at -40°C. 
Prior to analysis, aliquots were thawed on ice. 
2.2.3 Total protein quantification 
The most suitable method for quantifying total protein concentration in whole 
saliva samples was determined by comparing the Bradford Protein Assay Kit (Thermo 
Scientific, Rockford, IL) and the Pierce BCA Protein Assay kit (Thermo Scientific, 
Rockford, IL) for sensitivity and reproducibility. The Pierce BCA Protein Assay proved to 
be the most appropriate and was used to analyze all saliva samples. 
2.2.4 Protein separation via polyacrylamide gel electrophoresis 
Polyacrylamide gels were used in two modes (SDS and Anionic native) to 
separate proteins based on size and negative charge, respectively. Each sample was 
run individually to assess inter-individual variability in protein pattern. In addition, 
samples were pooled and run according to their group to identify inter-group variability. 
Polyacrylamide gels (8.3 X 7.3 cm X 0.1 cm, 10% acrylamide) were cast in a 
MiniPROTEAN® IV system (Bio-Rad, Hercules, California). The gels were pre-run at 30 
V for 30 minutes immediately prior to sample loading. SDS gels were loaded with 20 µg 
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of total protein, while Anionic gels required 100 µg of total protein to allow for sufficient 
protein separation and band visualization. The Anionic gels required a larger quantity of 
total protein to be loaded because this gel type separates only negatively charged 
species, unlike SDS gels which are able to separate proteins regardless of their charge. 
Negatively charged proteins constitute a fraction of the total proteins present in saliva, 
thus requiring more total protein loading in Anionic gels to provide sufficient quantities 
for visualization. Samples run on SDS-PAGE were placed in boiling water for 5 min and 
allowed to cool to room temperature prior to loading. While SDS is an effective 
denaturing agent, heating the samples further enhances the action of SDS by further 
disrupting protein structure. The gels were stacked and run at a constant voltage of 100 
V in a MiniPROTEAN® Tetra Cell (Bio-Rad, Hercules, California) for 1.5-2 h, or until the 
dye front had migrated to approximately 0.5 cm from the bottom edge of the gel. 
2.2.5 Gel imaging, image analysis and band quantification 
Coomassie Brilliant Blue and silver staining were tested for their suitability as a 
staining option for both SDS and Anionic PAGE gels. Coomassie and silver have 
detection limits of approximately 100 ng, and 1 ng, respectively (84). While silver 
staining has a much lower limit of detection, the narrow linear dynamic range, relative to 
Coomassie makes this staining method less suitable for quantification (84-86). Due to 
the importance of quantifying the protein profile in the gels, Coomassie was selected for 
use in this study over silver staining. All gels were stained with the colorimetric stain 
Coomassie Brilliant Blue (Thermo Scientific, Rockland, Illinois). To minimize 
background staining, destaining was achieved by incubating gels for 2 hours with 
destaining solution (40% Methanol, 10% Acetic Acid in milliQ dd H2O) under gentle 
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agitation, followed by 3 washes with milliQ ddH2O. Gel image acquisition was achieved 
using an Epson Perfection 4990 Photo scanner at the Best Scanning Quality, with 24-bit 
colour and 400 dpi. The scanned gels were analysed using TotalLab Quant v12.5. Band 
intensity was quantified and the gel-specific background subtracted to normalize 
intensity data. 
2.2.6 Protein separation via high performance liquid chromatography 
A reversed phase C4 column was chosen (XBridge™ BEH300 C4 3.5 µm, 4.6 
mm X 150 mm, Waters) to separate the complex mixture of whole proteins based on 
degree of hydrophobicity. To equally represent every individual from each group, 
equivalent amounts of protein were pooled for each run. Pooled protein samples 
containing 100 µg of total protein from each group were diluted with 0.1% TFA to reach 
a total volume of 1 mL. Pooled samples were syringe filter sterilized using a 0.2 µm 
Supor® Membrane (PN 4602, Pall Corporation, Ville St. Laurent Quebec) with a 1mL 
syringe (Reference number: 329650, Franklin Lakes, New Jersey). Immediately after 
filtration, samples were injected onto the equilibrated C4 column following a full blank 
method run to confirm the absence of carryover between samples. The method was 
initialized with 100% Buffer A (0.1% TFA in milliQ dd H2O) and gradually increased 
Buffer B (ACN + 0.1% TFA in milliQ dd H2O) concentrations until a final concentration of 
55% acetonitrile was reached with a 110 min method. A dual UV/Visible detector 
(Model: 2489, Waters) allowed for the simultaneous measurement of absorbance at 214 
nm and 280 nm to visualize both peptide and protein profile patterns across all groups.   
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2.2.7 Sample preparation for mass spectrometric analysis  
Due to the vast range of total protein concentrations determined in the samples, 
utilizing a protocol with a standardized volume would have resulted in a drastic over-
representation of samples with a high protein concentration, and an under-
representation of samples with a low protein concentration. Therefore, standardized 
weight was selected, rather than volume of saliva supernatant, to provide each 
individual with equal protein representation in the MS analysis. A total of 5 µg of total 
protein from each individual was combined in each pooled group sample. Low-protein 
binding 0.5 ml polypropylene microtube and low-protein binding tips were enlisted in 
every step of MS sample preparation to minimize protein loss prior to analysis. Pooled 
samples were aliquoted and immediately processed, or frozen at – 40°C.  Aliquots 
containing 15 µg of pooled total protein from each group were prepared as follows for 
LC MS/MS analysis. The final volume of each tube was brought to 50 µL with 4 M Urea, 
10 mM DTT, 50 mM NH4HCO3, pH 8.0) and incubated for 1 hour at room temperature 
(~25°C) to denature and reduce samples. Samples were then diluted 4-fold with 50 mM 
NH4HCO3, pH 8.0. Mass Spectrometry grade Trypsin was added 5% w/w (Promega) 
followed by incubation at 37°C for 16 h to complete proteolytic digestion. Samples were 
dried with an Eppendorf VacufugeTM. 
2.2.8 Mass spectrometric analysis 
Prior to analysis, samples were cleaned with a C18-ZipTip (Millipore, Watford, 
United Kingdom) to eliminate accumulated salts and denaturants (i.e. Urea) and 
optimize signal-to-noise ratio on spectra. Analyses were performed using liquid 
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chromatography with an Agilent 1100 Capillary LC system (Palo Alto, California) in-line 
with a linear ion trap quadrupole tandem mass spectrometer (Thermo Electron, San 
Jose, California). Digested proteins were separated with a C18 pre-column consisting of 
polyimide-coated fused silica capillary column (100 µm internal diameter X 5.0 cm 
length) (InnovaQuartz, Phoenix, Arizona) and a micro-liquid chromatography analytical 
column (75 µm X 10 cm) (Proxeon Biosystems, Odense, Denmark) with C18 resin (5 
µm diameter bead, 200 Å pore) (Varian, Palo Alto, California) that also functioned as a 
microelectrospray emitter. The reverse phase chromatography was achieved with an 80 
minute gradient elution from optima grade water to acetonitrile (Fisher Scientific, 
Ottawa, Ontario) each containing 0.1% formic acid (FA) (VWR, Mississauga, Ontario) 
and 0.2% protein sequencing grade trifluoroacetic acid (TFA) (Sigma-Aldrich, Oakville, 
Ontario) with an injection volume of 5 µL and a flow of 200 nL/min. The mass 
spectrometer was operated in data-dependent acquisition mode cycling automatically 
through acquisition of full-scan mass spectrum and three MS/MS spectra sequentially 
on the three most abundant ions present in the initial MS scan. All samples were run in 
duplicate with identical experimental parameters. 
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2.2.9 Searching the data base 
All MS/MS samples were analyzed using Mascot (version 2.2, Matrix Science, 
London, United Kingdom) and X! Tandem (version 2007.01.01.1). The samples were 
searched against the NCBInr database assuming trypsin digestion. Mascot and X! 
Tandem were searched with a fragment ion mass tolerance of 0.05 Da and a parent ion 
tolerance of 3.0 Da. In Mascot, variable modifications were specified as follows: 
Oxidation of methionine, deamination of asparagine, deamination of unknown, 
acetylation and carbamylation of the n-terminus. No fixed modifications were specified. 
Scaffold (version Scaffold_2_06_02, Proteome Software Inc., Portland, Oregon) 
was enlisted to validate MS/MS based peptide and protein identifications. Peptide 
identifications with a greater than 95.0% probability were accepted  (87). Protein 
identifications with a greater than 95.0% probability, as well as a minimum of 1 identified 
peptide, were assigned by the Protein Prophet algorithm  (88).  
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2.3 Results 
2.3.1 Comparison of total protein quantification methods 
Two protein quantification methods, Bradford and bicinchoninic acid (BCA) 
assay, were compared to determine the most suitable technique for total protein 
quantification of unstimulated whole saliva samples. Both methods are widely used to 
quantify protein concentrations in proteomic studies.  
The BCA assay is similar to the Lowry method, with the added advantage of 
increased sensitivity. It relies on protein forming complexes with Cu2+ under alkaline 
conditions followed by the release of Cu+ from the reduction of the copper-protein 
complexes, leading to a colorimetric change. The amount of protein present determines 
the amount of reduction and resulting quantifiable colour modification. This method 
measures the amount of cysteine, cystine, tryptophan, tyrosine and peptide bonds, all of 
which are capable of reducing Cu2+ to Cu+. When measured at 592 nm, the linear 
working range of the BCA assay reaches 2,000 µg/ml, well above the average total 
protein concentration of whole saliva of approximately 1,000 µg/ml.  
The Bradford assay has the advantage of working very quickly and requiring 
small amount of sample. Minimizing the amount of limited biological sample required is 
of great importance. However, the assay sensitivity is poor, relative to the BCA assay. 
The Bradford method uses Coomassie Brilliant Blue dye to bind protein through 
hydrophobic and ionic interactions. The anionic form of the dye is stabilized through this 
protein binding, resulting in a colour change detected at 595 nm. The linear working 
range of the Bradford assay is limited to at or below 1,000 µg/ml.  
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The most suitable protein quantification assays are those in which the properties 
being measured are equally distributed within all samples. The BCA assay’s detection 
of peptides bonds and four amino acids in salivary samples is much more 
representative of the total protein concentration than the less uniformly distributed 
hydrophobic and ionic interactions detected by the Bradford method. 
Ultimately, due to the requirement of a larger linear working range, heightened 
sensitivity, and a reliable total protein concentration measurement for each sample, the 
BCA assay was selected, a stable, reliable, reproducible method, appropriate for protein 
concentrations from 20-2,000 µg/ml. Bovine serum albumin, a common protein standard 
used in salivary proteomic studies, was selected as protein standard for the total protein 
quantification assays. 
2.3.2 Total protein quantification 
All saliva samples collected from 44 individuals from 4 groups (Group A: Children 
pre-dental eruption (no teeth), Group B: Children during dental eruption (partial primary 
dentition), Group C: Children post-dental eruption (complete primary dentition), Group 
D: Adults edentulous (complete denture patients)) were subject to total protein 
concentration quantification using the BCA assay. The results are summarized in Table 
2.4. 
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Table 2.4 Summary of total protein concentration in collected saliva samples from all four groups, 
Group A (pre-dental eruption), B (during dental eruption), C (post-dental eruption), and D (adult 
controls) as measured with the BCA assay. The individuals ranged in age from 2 wks – 61.75 
years of age.  
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Clinical Parameters with Total Protein Concentration 
GROUP A –Children –pre-dental eruption 
    Age (# of months) Sex Protein concentration [µg/mL] Teeth erupted (#) 
A001  7.00 F 508.64 0 
A002  2.75 M 585.00 0 
A003  0.75 M 1205.63 0 
A004  5.75 M 886.18 0 
A005  6.50 M 235.45 0 
A006  6.75 F 379.27 0 
A007  6.50 M 506.36 0 
A008  2.75 M 1679.27 0 
A009  4.25 F. 745.81 0 
A010  5.50 F 522.00 0 
A011  4.75 F 854.18 0 
A012  2.75 F 284.73 0 
GROUP B –Children –during dental eruption (Partial Primary Dentition) 
    Age (# of months) Sex Protein concentration [µg/mL] Teeth erupted (#) 
B001  6.50 F 580.27 4 
B002  6.25 M 346.73 1 
B003  12.25 M 972.82 7 
B004  23.00 M 704.55 16 
B005  16.00 M 448.55 2 
B006  15.25 F 3207.27 6 
B007  19.25 M 967.27 14 
B008  9.75 F 463.09 6 
B009  19.75 M 689.64 16 
B010  14.00 M 833.45 8 
GROUP C –Children – post dental eruption (Complete Primary Dentition) 
    Age (# of months) Sex Protein concentration [µg/mL] Teeth erupted (#) 
C001  35.50 F 1084.18 20 
C002  39.25 F 821.09 20 
C003  42.00 M 957.18 20 
C004  23.50 F 797.64 20 
C005  41.75 M 1362.73 20 
C006  38.00 M 932.49 20 
C007  31.50 M 751.55 20 
C008  37.75 M 1280.36 20 
C009  29.00 M 1484.18 20 
C010  31.00 F 1003.09 20 
C011  31.75 M 495.64 20 
C012  29.00 M 1260.36 20 
GROUP D –Adults – edentulous (Complete Denture Patients) 
  
Age (# yrs) Sex Protein concentration [µg/mL] Teeth present (#) 
D004 (1) 58.83 F 1421.94 0 
D005 (2) 44.50 F 826.90 0 
D006 (3) 47.08 F 1583.16 0 
D008 (4) 49.75 M 852.26 0 
D009 (5) 61.75 F 848.64 0 
D010 (6) 37.58 F 969.09 0 
D011 (7) 35.00 M 2074.05 0 
D012 (8) 55.08 M 1393.87 0 
D013 (9) 52.33 M 5398.86 0 
D014 (10) 56.00 M 1181.09 0 
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2.3.3 Statistical analyses of clinical data 
In order to identify any significant trends or differences in the clinical data, a 
statistical analysis was enlisted. The clinical parameters of age, sex, number of teeth 
present, and protein concentration in collected saliva samples were subjected to 
analysis. The nonparametric nature of the collected data was examined with the 
Kruskal-Wallis, the Mann-Whitney U Test, and Spearman’s analysis. SPSS statistics 
was the software chosen to complete the statistical analysis of the clinical data. 
Statisticians regard SPSS as the gold standard software for statistical analyses.  
The Kruskal-Wallis hypothesis test is a nonparametric one-way analysis of 
variance. It is useful in the comparison of more than two independent samples. A 
significant result from a Kruskal-Wallis test states that a minimum of one of the samples 
is different from the other samples. The Kruskal-Wallis hypothesis test determined that 
the distribution of the protein concentration was the same across all four groups. The 
Kruskal-Wallis test also determined that the distribution of the volume of saliva collected 
was the same across all four groups. 
The second nonparametric analysis enlisted was the Mann-Whitney U 
hypothesis test. This test analyzes for significant differences between specific sample 
pairs. The Mann-Whitney U hypothesis test works from a null hypothesis describing two 
groups as the same opposed to an alternative hypothesis.  
In accordance with the Kruskal-Wallis test, The Mann-Whitney U hypothesis test 
also determined that the distribution of the volume of saliva collected was the same 
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across all four groups. Both the Kruskal-Wallis test and the Mann-Whitney U test level 
of significance were set at 0.05. 
Spearman’s analysis, often referred to as Spearman’s rho, is the third 
nonparametric test applied to this clinical data set. This analysis measures two 
variables’ statistical dependence upon each other.  
Spearman’s rho determined there was a significant correlation between age and 
protein concentration in the collected samples, with a correlation coefficient of 0.48 
(n=44) at the level of 0.01. A significant correlation was still seen when the males and 
females were tested separately for correlations between age and protein concentration. 
Males (n=26) and Females (n=18) had correlation coefficients of 0.635 at the level of 
0.01 and 0.42 at the level of 0.05, respectively.  Spearman’s analysis determined no 
significant correlation between volume of saliva and protein concentration, volume of 
saliva and age, and finally, protein concentration and teeth erupted.    
Appendix 3 includes the tabulated results of the clinical data and statistical 
analyses of the Kruskal-Wallis hypothesis test, the Mann-Whitney U hypothesis test, 
and the Spearman’s analysis. 
Making use of the measured total protein concentrations in this study, a future 
sample size calculation was completed to inform the determination of sample sizes in 
future studies. The calculated mean values of the youngest (Group A) and oldest 
children (Group C), and their associated standard deviations were used, as they 
represented the pre- and post-dental eruption populations, a primary focus of this 
research. With clinical consultation determined a clinically relevant difference limit of 
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200 µg/mL of total protein concentration between groups. A power of 0.80, and an alpha 
of 0.05 were the standard values assigned to this calculation, representing an 80% 
chance of detecting a clinically relevant difference when one is present, and a 5% 
chance of detecting a clinically relevant difference when there is none. Using these 
parameters, a future sample size is recommended to be 48 per group (n = 48), bringing 
a study with four groups to a total study size of 192 (n = 192).  
2.3.4 Protein separation via polyacrylamide gel electrophoresis 
Polyacrylamide gel electrophoresis was used to separate proteins based on 
negative charge (Anionic-PAGE) and size (SDS-PAGE). Loading each lane of a gel with 
a sample from a single individual allowed the assessment of intra-group variability, a 
visual representation of differences between individuals of a single group. Inter-group 
variability, the differences between groups, was assessed by pooling samples from 
Group A and running the resultant pooled samples in a single lane alongside individual 
lanes of pooled samples from Group B, C and D. 
 Protein profiles were quantified first using Photoshop followed by TotalLab Quant 
v12.5. Photoshop allowed for pixel counts of individual bands, but was unable to take 
into account the intensity of the stained protein. Band density can vary even within the 
same gel. Therefore, using only a count of pixels and not intensity, large diffuse protein 
bands were often overestimated, while small densely packed bands were largely 
underestimated for the amount of protein they contain. In order to take band intensity 
into proper account, to achieve a truly accurate measurement of protein quantity in all 
cases, gels were re-analyzed and bands re-quantified using TotalLab Quant v12.5. With 
the ability to consider band intensity as well as band surface area, TotalLab Quant 
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v12.5 allowed for the quantification and comparison of protein profiles from all individual 
and group samples successfully. 
2.3.5 Anionic PAGE 
The following section displays the anionic PAGE comparing pooled protein from 
each of the four groups run alongside purified human serum albumin. The stacking gel 
was maintained atop the separating gel to confirm the large amount of protein that was 
unable to enter the separating gel to be separated and visualized in this manner. The 
resultant band intensity quantification as measured by TotalLab Quant v12.5 is also 
displayed in this section. 
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Figure 2.3 - Anionic-PAGE Inter-group variability. Each lane represents protein pooled from all the 
individuals in a single group (100 µg loaded in each lane). Gel was stained with Coomassie 
Brilliant Blue. Lane indicated with an ‘X’ was loaded with 4 µg of human salivary protein standard - 
human serum albumin (HSA). Lanes A, B, C, and D represent pooled samples from Groups A, B, 
C, and D, respectively. 
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Figure 2.4 - Inter-group variability visualization through band intensity quantification of anionic-
PAGE. Each line represents the relative intensity of stained salivary protein from each lane 
consisting of pooled samples from all the individuals in a single group. 
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2.3.6 SDS PAGE 
The following section displays the SDS PAGE comparing individual saliva 
samples run along a molecular weight standard ranging from 10-250 kDa. The stacking 
gel was maintained atop the separating gel to confirm that the vast majority of proteins 
were not retained at the interface between the stacking gel and the separating gel, 
unlike the large amount of protein that was unable to enter the separating gel to be 
separated and visualized in the anionic PAGE seen earlier. The resultant band intensity 
quantification as measured by TotalLab Quant v12.5 is also displayed in this section.  
Through the quantification of band intensities in the gel run with pooled saliva 
samples from each group (Inter-group gel, Fig 2.10), and the summation of intensities 
all the individual profiles seen in the intra-group gels (Fig. 2.5) a comparison of trends 
can be drawn between the two methods (non-pooled intra-group gels, and pooled inter-
group gels). A summary of this comparison is displayed in Figures 2.11 and 2.12.
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Figure 2.5 - SDS-PAGE Intra-group variability.  A), B), C), and D) display results from Groups A, B, 
C, and D respectively. Gels are seen here stained with Coomassie Brilliant Blue. Furthermost left 
lane in each gel was loaded with a molecular weight marker, numbers indicating kilo Daltons 
(kDa). Each lane to the right of the molecular weight marker represents 20 µg of total protein from 
a single individual, therefore each lane represents a different individual. 
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Figure 2.6 - Group A - Intra-group variability visualization through band intensity quantification of SDS-PAGE. Each line represents the 
relative intensity of stained protein from each lane consisting of salivary proteins from a single individual in Group A (Children pre-
dental eruption) from Figure 2.5 A. 
  
 
 
  
 
 
 
 
 
 
 
 
Figure 2.7 - Group B - Intra-group variability visualization through band intensity quantification of SDS-PAGE. Each line represents the 
relative intensity of stained protein from each lane consisting of salivary proteins from a single individual in Group B (Children during 
dental eruption) from Figure 2.5 B. 
  
 
 
  
 
 
 
 
 
 
 
 
Figure 2.8 - Group C - Intra-group variability visualization through band intensity quantification of SDS-PAGE. Each line represents the 
relative intensity of stained protein from each lane consisting of salivary proteins from a single individual in Group C (Children post-
dental eruption) from Figure 2.5 C. 
  
 
  
 
 
 
 
 
 
 
 
Figure 2.9 - Group D - Intra-group variability visualization through band intensity quantification of SDS-PAGE. Each line represents the 
relative intensity of stained protein from each lane consisting of salivary proteins from a single individual in Group D (Adult controls) 
from Figure 2.5 D. 
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Figure 2.10 - SDS-PAGE Inter-group variability. Each lane represents protein pooled from all the 
individuals in a single group (20 µg loaded in each lane). Lanes A, B, C, and D represent all the 
pooled samples from Group A (Children pre-dental eruptions), Group B (Children during dental 
eruption), Group C (Children post dental eruption), and Group D (Adult controls), respectively. Gel 
is seen here stained with Coomassie Brilliant Blue. Furthermost left lane was loaded with a 
molecular weight marker, numbers indicating kilo Daltons (kDa). 
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Figure 2.11 - SDS-PAGE Inter-group variability. Each line represents the quantified intensities of a 
single lane visualized on the single gel displayed in Figure 2.10. Each lane of the gel represents 
protein pooled from all the individuals in a single group. Lines A, B, C, and D represent all the 
quantified band intensities of pooled samples from Group A (Children pre-dental eruptions), 
Group B (Children during dental eruption), Group C (Children post dental eruption), and Group D 
(Adult controls), respectively. 
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Figure 2.12 -. SDS-PAGE Inter-group variability measured on the four separate gels displayed in 
Figure 2.5 A, B, C, D, representing Group A (Children pre-dental eruptions), Group B (Children 
during dental eruption), Group C (Children post dental eruption), and Group D (Adult controls). 
Each line in this figure represents the quantified intensities summed across one of the four 
separate gels seen in Figure 2.5. Lines A, B, C, and D represent all the quantified band intensities 
across all the lanes in Figure 2.5A, B, C, and D, respectively. 
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2.3.7 High performance liquid chromatography 
High performance liquid chromatography (HPLC) was used in two capacities in 
this study. The first application provided another avenue of protein separation and 
independent visualization of the whole protein profiles present in saliva in all four 
groups. The second application of HPLC was in-line with the mass spectrometer, 
serving to separate trypsin digestion protein fragments immediately prior to mass 
spectrometric analysis.   
 HPLC provides an excellent method of visualizing profiles of protein 
mixtures, separating proteins based on a range of properties (i.e. hydrophobicity, net 
charge, size/shape, metal binding etc.). In order to gain information about the whole 
protein profile of each group, the HPLC was used to analyze whole protein (avoiding 
tryptic-digestion) samples pooled from all individuals in each group. To add a unique 
dimension of separation not previously achieved with the PAGE analysis (Anionic – 
separated proteins based on their negative charge, SDS – separated proteins based on 
their molecular weight), a reverse phase column has been selected separate based on 
protein hydrophobicity. The column selected for sample analysis was a C4 XBridgeTM 
column. After extensive method optimization, the column proved its ability to 
reproducibly separate the complex protein mixture found in whole saliva, as well as 
parotid saliva. Parotid saliva served as a less-complex protein mixture but with much in 
common with whole saliva. Being far less complex in nature, the use of parotid saliva 
reduced unnecessary loading on the column during the comprehensive optimization 
process.  
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Chromatograms indicating successful and reproducible protein profile acquisition 
are displayed in Figures 2.13-2.16.  
Once appropriate gradient range was established, flow rate and amount of 
protein loaded was optimized for consistent visualization and separation of peaks while 
minimizing the required amount of limited biological sample. Figures 2.13 and 2.14 
displays chromatograms of protein profiles with loading of either 50 µg or 100 µg of total 
protein from parotid saliva. Figures 2.15 and 2.16 displays the same process applied to 
unstimulated whole saliva. 
The detection sensitivity of the HPLC with the optimized method for C4 RP-HPLC 
column was determined through the use of isolated protein (albumin) loaded in known 
concentrations. The resulting single peak in each chromatogram was integrated to 
relate the area under the curve (AUC) with the amount of protein loaded. This forms the 
basis for quantitative analysis of visualized peaks in sample-derived chromatograms by 
relating peak size with a previously quantified value. The results of the relationship 
between the area under the curve and amount of isolated albumin protein over a range 
of concentrations (1.25µg–25µg) are displayed in Figure 2.17, with the raw 
chromatograms included in Appendix 4. 
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Figure 2.13 - Triplicate chromatograms produced by loading a total of 50 µg of parotid saliva 
protein on the C4 XBridgeTM column. The chromatograms display the pattern of isolated parotid 
saliva separated on the reverse-phase C4 column run with a method of increasing organic solvent 
to a final concentration of 55% acetonitrile and 0.1% TFA. 
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Figure 2.14 - Triplicate chromatograms produced by loading a total of 100 µg of parotid saliva 
protein on the C4 XBridgeTM column. The chromatograms display the pattern of isolated parotid 
saliva separated on the reverse-phase C4 column run with a method of increasing organic solvent 
to a final concentration of 55% acetonitrile and 0.1% TFA.
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Figure 2.15 - Triplicate chromatograms produced by loading a total of 50 µg of unstimulated whole 
saliva protein on the C4 XBridgeTM column. The chromatograms display the pattern of 
unstimulated whole saliva separated on the reverse-phase C4 column run with a method of 
increasing organic solvent to a final concentration of 55% acetonitrile and 0.1% TFA. 
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Figure 2.16 – Triplicate chromatograms produced by loading a total of 100 µg of unstimulated 
whole saliva protein on the C4 XBridgeTM column. The chromatograms display the pattern of 
unstimulated whole saliva separated on the reverse-phase C4 column run with a method of 
increasing organic solvent to a final concentration of 55% acetonitrile and 0.1% TFA. 
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Figure 2.17 - Relationship between area under the curve and amount of HSA loaded onto the C4 
XBridgeTM column. The area under the curve (AU*time) was measured for quantities of HSA 
ranging from 5 – 60 µg. 
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Figure 2.18 – Chromatograms A, B, C, and D, represent 100 µg of pooled unstimulated whole saliva from Groups A (Children pre-dental 
eruption), B (Children during dental eruption), C (Children post dental eruption), and D (Adult controls), respectively, on a C4 X-Bridge 
reverse-phase column. The chromatograms display the pattern of unstimulated whole saliva separated on the reverse-phase C4 column 
run with a method of increasing organic solvent to a final concentration of 55% acetonitrile and 0.1% TFA. A minimum of ten of the most 
prominent and shared peaks from each chromatogram were highlight for comparison between groups. 
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Once the method was proven to be consistent and able to successfully separate 
the proteins found in unstimulated whole saliva, the pooled unstimulated whole saliva 
samples from each of the four groups were loaded and chromatograms compared. 
Figure 2.18 displays an overview of the entire 90-minute method for all four groups. 
Appendix 5 includes more detailed views of the chromatographic patterns throughout 
the length of the chromatographic run. 
2.3.8 Mass spectrometric analysis 
Mass spectrometric results are summarized in Table 2.5. A total of 79 proteins 
were successfully identified in one or more of the four pooled sample groups. A total of 
48, 48, 58, and 50 proteins were successfully identified in pooled samples from Groups 
A, B, C, and D, respectively.   
Table 2.6 summarizes the quantification of relative abundance of the top 15 
identified proteins by Scaffold with a minimum cut-off of 2 unique peptide counts, if a 
peptide was detected at all. In this study, the count of unique peptides represents the 
number of unique parent ions, identified for a protein, that meet the default minimum 
intensity limit for MS/MS analysis. The term spectrum counts represents the total 
number of MS/MS fragmentation spectra that map to peptides of a given protein. 
Unique spectrum counts is the sum of nonrepeated MS/MS fragmentation spectra, 
represented as a subset of the total spectrum counts.  
 
  
 
 
 
 
 
 
 
 
Table 2.5 –Mass spectrometric protein identifications for children pre-, during, post-eruption, and edentulous adults, Groups A, B, C, D, 
respectively. This table summarizes the name, accession number, molecular weight, and number of unique peptide counts, for each of 
the 79 identified proteins, across Groups A, B, C, and D. The numbers corresponding to each protein identified in each group 
represents the number of unique peptide counts. The MS/MS results were analyzed using Mascot (version 2.2) and X! Tandem (version 
2007.01.01.1), and searched against the NCBInr database. Scaffold (version Scaffold_2_06_02) was used to validate the search results, 
with an acceptable peptide probability of greater than 95.0%. The number zero (0) indicates no peptides were detected from the 
specified protein. 
  
 
# Identified Proteins (79) Accession Number 
Molecular 
Weight 
Group 
A 
Group 
B 
Group 
C 
Group 
D 
1 Chain A, Structure Solution And Refinement Of The Recombinant Human Salivary Amylase gi|14719766 (+1) 56 kDa 37 34 37 23 
2 albumin, isoform CRA_h [Homo sapiens] gi|119626071 (+11) 69 kDa 12 20 20 12 
3 peptide PB,saliva gi|350218 6 kDa 7 10 14 14 
4 mucin-5B precursor [Homo sapiens] gi|301172750 596 kDa 16 11 11 7 
5 unnamed protein product [Homo sapiens] gi|189053131 (+2) 19 kDa 10 8 12 10 
6 Polymeric immunoglobulin receptor [Homo sapiens], transmembrane secretory component gi|238236 (+2) 83 kDa 11 11 11 6 
7 parotid secretory protein [Homo sapiens] gi|16755850 (+1) 27 kDa 12 7 8 7 
8 unnamed protein product [Homo sapiens] gi|14042015 53 kDa 7 9 10 7 
9 hypothetical protein LOC352999 precursor [Homo sapiens] gi|58219024 38 kDa 8 6 10 6 
10 carbonic anhydrase VI [Homo sapiens] gi|119592012 35 kDa 7 7 6 6 
11 Chain B, Mhc-Like Zinc Alpha2-Glycoprotein And Prolactin Inducible Protein gi|145579641 14 kDa 5 6 6 6 
12 Mucin 7, secreted [Homo sapiens] gi|19343619 (+1) 39 kDa 9 7 4 3 
13 Chain A, Zn-Alpha-2-Glycoprotein gi|58176763 32 kDa 5 7 7 4 
14 lactoperoxidase isoform 1 preproprotein [Homo sapiens] gi|40549418 80 kDa 12 2 4 5 
15 lipocalin-1 precursor [Homo sapiens], von Ebner's gland protein gi|4504963 19 kDa 8 10 5 0 
16 cystatin SA-III=potential precursor of acquired enamel pellicle gi|235948 (+1) 14 kDa 1 7 7 7 
17 actin, beta [Homo sapiens] gi|14250401 (+9) 41 kDa 2 5 8 2 
18 bactericidal/permeability-increasing protein-like 1 precursor [Homo sapiens] gi|15055535 (+1) 49 kDa 4 3 4 5 
19 small proline-rich protein 3 [Homo sapiens] gi|4885607 (+3) 18 kDa 3 0 6 7 
20 deleted in malignant brain tumors 1, isoform CRA_b [Homo sapiens] gi|119569694 (+14) 178 kDa 6 3 5 2 
21 cystatin-SA precursor [Homo sapiens] gi|4503105 16 kDa 1 4 6 4 
22 cystatin-B [Homo sapiens] gi|4503117 11 kDa 4 4 3 4 
23 cystatin-SN precursor [Homo sapiens] gi|19882251 (+1) 16 kDa 1 3 4 5 
24 unnamed protein product [Homo sapiens] gi|158256038 (+2) 54 kDa 2 2 3 5 
25 immunoglobulin light chain [Homo sapiens] gi|149673889 23 kDa 1 3 4 3 
26 suprabasin isoform 1 precursor [Homo sapiens] gi|260436922 61 kDa 4 1 4 2 
27 Ig L-chain V-region [Homo sapiens] gi|27552515 (+1) 23 kDa 1 3 5 2 
28 unnamed protein product [Homo sapiens] gi|158261509 (+3) 52 kDa 3 7 1 0 
29 Chain A, Human Cystatin C gi|14278690 (+1) 13 kDa 2 1 5 1 
30 transcobalamin-1 precursor [Homo sapiens] gi|21071008 48 kDa 4 1 1 3 
31 beta-casein [Homo sapiens] gi|288098 (+1) 25 kDa 8 0 0 0 
32 beta-2-microglobulin precursor [Homo sapiens] gi|114319049 (+23) 12 kDa 3 3 2 0 
33 cystatin D [Homo sapiens] gi|398711 (+1) 16 kDa 0 2 3 2 
34 Chain B, T-To-T(High) Quaternary Transitions In Human Hemoglobin gi|60594354 (+30) 16 kDa 0 0 7 0 
35 
Chain A, Role Of Amino Acid Residues At Turns In The Conformational Stability And Folding Of Human 
Lysozyme gi|6730358 15 kDa 2 2 1 1 
36 keratin 1 [Homo sapiens] gi|11935049 (+3) 66 kDa 1 1 2 2 
37 monoclonal IgM antibody heavy chain [Homo sapiens] gi|41388180 64 kDa 0 3 3 0 
38 histatin-1 precursor [Homo sapiens] gi|4504529 7 kDa 3 1 0 1 
  
  
Table 2.5 (Continued): 
# Identified Proteins (79) Accession Number 
Molecular 
Weight 
Group 
A 
Group 
B 
Group 
C 
Group 
D 
39 salivary proline-rich protein precursor [Homo sapiens] gi|190510 25 kDa 0 2 0 3 
40 hCG2006898 [Homo sapiens] gi|119571628 16 kDa 1 0 1 3 
41 hypothetical protein [Homo sapiens] gi|34365139 52 kDa 2 1 1 1 
42 immunoglobulin J chain [Homo sapiens] gi|114319027 (+2) 20 kDa 1 2 2 0 
43 PREDICTED: nucleobindin 2 isoform 2 [Pan troglodytes] gi|114636384 (+5) 50 kDa 2 0 2 1 
44 peptide,salivary low MW gi|223364 1 kDa 1 1 2 0 
45 hemoglobin alpha-1 globin chain [Homo sapiens] gi|13650074 (+16) 15 kDa 0 0 4 0 
46 Chain A, Crystal Structure Of Pi Class Glutathione Transferase gi|11514448 (+22) 23 kDa 2 0 0 2 
47 kallikrein 1, renal/pancreas/salivary, isoform CRA_b [Homo sapiens] gi|119592319 (+10) 24 kDa 0 0 2 2 
48 RecName: Full=Ig kappa chain C region [Homo sapiens] gi|125145 (+2) 12 kDa 0 0 2 2 
49 Chain A, Crystal Structure Of Human Enolase 1  gi|203282367 (+5) 47 kDa 0 0 3 1 
50 lactotransferrin [Homo sapiens] gi|119585171 (+28) 78 kDa 3 1 0 0 
51 unnamed protein product [Homo sapiens] gi|189053201 (+3) 13 kDa 0 0 1 3 
52 beta-casein [Homo sapiens] gi|29674 7 kDa 3 0 0 0 
53 RecName: Full=Vitamin D-binding protein [Homo sapiens] gi|139641 (+9) 53 kDa 0 2 1 0 
54 hypothetical LOC389429, isoform CRA_a [Homo sapiens] gi|119568478 31 kDa 0 2 1 0 
55 alpha-2-macroglobulin-like 1, isoform CRA_b [Homo sapiens] gi|119609009 (+4) 161 kDa 0 1 0 2 
56 albumin, isoform CRA_p [Homo sapiens] gi|119626079 (+2) 23 kDa 1 0 2 0 
57 cystatin-A [Homo sapiens] gi|4885165 11 kDa 0 0 0 3 
58 unnamed protein product [Homo sapiens] gi|194387966 (+3) 17 kDa 0 0 1 2 
59 Chain A, Apo-Human Serum Transferrin (Non-Glycosylated) gi|110590597 75 kDa 0 0 3 0 
60 unnamed protein product [Homo sapiens] gi|34526199 53 kDa 0 1 1 0 
61 Chain A, Alpha-Lactalbumin [Homo sapiens] gi|157829683 (+2) 14 kDa 2 0 0 0 
62 immunoglobulin variable region [Homo sapiens] gi|323432327 15 kDa 0 1 1 0 
63 desmoglein-3 preproprotein [Homo sapiens] gi|119964718 (+2) 108 kDa 0 0 2 0 
64 Chain A, High Resolution Crystal Structure Of The Unliganded Human Acbp gi|118137768 (+1) 10 kDa 0 0 0 2 
65 extracellular glycoprotein lacritin precursor [Homo sapiens] gi|15187164 14 kDa 0 2 0 0 
66 mammaglobin-B precursor [Homo sapiens] gi|4505171 11 kDa 0 2 0 0 
67 cysteine-rich secretory protein 3 [Homo sapiens] gi|119624753 (+6) 26 kDa 2 0 0 0 
68 basic salivary proline-rich protein 3 precursor [Homo sapiens] gi|117306167 (+4) 31 kDa 0 0 0 2 
69 alpha-amylase [Homo sapiens] gi|178585 58 kDa 2 0 0 0 
70 interleukin-1 receptor antagonist protein isoform 3 [Homo sapiens] gi|10835147 (+5) 18 kDa 0 0 0 2 
71 unnamed protein product [Homo sapiens] gi|158256510 68 kDa 0 0 0 2 
72 Chain A, Mixed Disulfide Intermediate Between Mutant Human Thioredoxin And A 13 Residue Peptide gi|1065111 (+15) 12 kDa 0 0 0 2 
73 hypothetical protein LOC644054 [Homo sapiens] gi|212276011 (+1) 9 kDa 0 0 0 2 
74 glyceraldehyde-3-phosphate dehydrogenase, isoform CRA_a [Homo sapiens] gi|119609192 (+7) 35 kDa 0 0 2 0 
75 complement C3 precursor [Homo sapiens] gi|115298678 (+2) 187 kDa 0 0 1 0 
76 unnamed protein product [Homo sapiens] gi|194373909 (+5) 51 kDa 0 0 1 0 
77 secretoglobin family 1D member 1 precursor [Homo sapiens] gi|5729907 10 kDa 0 1 0 0 
78 Casein alpha s1 [Homo sapiens] gi|118764211 (+6) 22 kDa 1 0 0 0 
79 lectin, galactoside-binding, soluble, 3 binding protein, isoform CRA_a [Homo sapiens] gi|119609949 (+7) 65 kDa 0 0 1 0 
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Figure 2.19 – Venn Diagrams describing the number of proteins identified in Group A (Children 
pre-dental eruption), B (Children during dental eruption), C (Children post dental eruption), and D 
(Adult controls).  a) TOP Venn Diagram represents the number of proteins identified in the four 
groups with a minimum of 1 or more unique peptides identified with MS/MS. b) BOTTOM Venn 
Diagram represents the number of proteins identified in the four groups with a minimum of 3 or 
more unique peptides identified with MS/MS. 
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Table 2.6 – Summary of 15 most abundant proteins from mass spectrometric protein identifications for children pre-, during, post-
eruption, and edentulous adults, Groups A, B, C, D, respectively. This table summarizes the name, molecular weight, number of unique 
peptide counts, spectrum counts, and unique spectrum counts for the top 15 most abundant proteins across Groups A, B, C, and D, 
identified in Table 2.5. Scaffold (version Scaffold_2_06_02) was used to validate the search results, with an acceptable peptide 
probability of greater than 95.0%. The number zero (0) indicates no peptides and therefore no spectra were detected from the specified 
protein. 
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2.4 Discussion  
2.4.1 Importance of Sample Preparation and Experimental Design 
Importance of Sample Preparation 
Sample preparation, including collection, storage and processing is of 
fundamental importance when working with whole saliva. During the analysis of whole 
saliva, one must keep in mind the multiple sources that contribute to saliva’s 
composition, including host-derived and exogenously introduced substances. Ordinary 
activities, such as brushing one’s teeth, may be sufficient activity to cause minor injury 
and introduce serum components into whole saliva. Salivary composition is influenced 
by enzymatic activity of both host and bacterially derived proteins. This influence can be 
mitigated through careful collection, storage and processing techniques. Such 
techniques include collecting and storing samples at temperatures that inhibit 
metabolism, centrifuging saliva samples immediately after collection to eliminate 
bacterial and cellular debris. Adding enzyme inhibitors to collection tubes to prevent 
protein cleavage post-collection, as well as during storage and processing is a 
potentially useful measure to be taken to protect the biochemical properties of saliva 
samples in future studies. The practical aspects of sample collection and analysis are of 
fundamental importance to the completion and interpretation of this thesis and salivary 
research as a whole. 
The effects of quality handling of samples on the biochemical properties and 
composition of saliva should not be underestimated. This is especially the case when 
dealing with studies in children. As was the case in this research, the precisely 
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controlled and monitored collection of unstimulated whole saliva samples from healthy 
children presented more challenges in some respects than the collection of 
unstimulated whole saliva from adult controls. It was imperative to maintain a consistent 
collection protocol in all sample collections, including the requirement of all collections 
to be performed: during the same limited window of time during the day, from individuals 
in good health who had not had anything to eat or drink for a full hour before the time of 
collection, for all individuals to be at rest before collection starts and to maintain the 
state of rest until sample collection is completed, and for all individuals to be free of 
medications. The significance of ensuring all individuals were free of medications is 
outlined later in this discussion. Ensuring all of these criteria were fully met for each 
collection was a source of difficulty in collecting saliva from children. Special mention is 
given to the challenge of the maintenance of a restful state in very young children 
before and during saliva collection. 
Being aware of, and controlling as many variables as possible in the collection 
process reduces the number of potential confounders that may affect the composition of 
saliva unrelated to the hypothesis being tested, such as the variation in the salivary 
proteome with age/developmental stage, at the focus of this work. 
Once collected, the processing of samples became of primary importance. 
Salivary samples were never left at room temperature during processing or storage. 
Unless the samples were actively being processed, they were kept frozen. The handling 
of saliva requires mindful planning of the number of times a single saliva sample 
requires freezing and thawing. During the freeze-thaw cycle, some salivary proteins 
(namely the large glycoproteins of the mucin family) come out of solution. The 
99 
 
precipitation of proteins out of solution can be greatly prevented through limiting the 
number of freezes and thaws experienced by a sample. Samples can generally be 
safely frozen twice before any noticeable changes in the consistency of the saliva 
appears.  
A consideration to keep in mind is the importance of standardizing methods of 
sample collection and processing between studies to enable wide-scale comparison of 
findings. A standard method of processing whole saliva samples described throughout 
the literature includes the centrifugation of samples followed by the collection and 
analysis of the supernatant. The whitish pellet that remains at the bottom of the 
centrifuged tube is rarely discussed. The composition of the pellet may also prove to be 
a useful source of biological information, as proteins and other molecules of potential 
interest, may be trapped in the debris. 
Importance of Experimental Design 
The selection of techniques in this study of the changes in the salivary proteome 
during the course of dental eruption was designed to offer as much useful information 
as possible with the amount of samples collected. As previously mentioned, both 1- and 
2-dimensional PAGE (1D- and 2D-PAGE) are effective methods of protein separation 
and have been widely used to separate salivary proteins  (4, 6, 14, 29, 81). Both 
methods provide visuals of profiles of protein mixtures that can be used to assess 
variability between samples, people, and groups. 2D-PAGE is a powerful technique of 
protein separation but harbors significant limitations that remain highly relevant in 
salivary protein research. 2D-PAGE is ill suited for the detection of small MW proteins, 
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highly acidic or basic proteins, highly hydrophobic proteins, as well as proteins in low 
abundance (6). The presence of many small MW proteins and peptides, as well as a 
significant number of highly acidic, basic, hydrophobic and proteins present in very low 
concentrations in saliva, makes it clear that 2D-PAGE is not of great use to study the 
changes in the complete salivary proteome. Instead, two varieties of 1D-PAGE were 
employed to separate and visualize proteins in their native state (anionic PAGE) and in 
a denatured state (SDS-PAGE). With the use of both the negative charge (anionic) and 
molecular weight (SDS) as differentiating characteristics, a third mode of separation and 
visualization was then employed. Reverse-phase HPLC was used to separate whole 
proteins based on their degree of hydrophobicity. The fourth technique for protein 
analysis involved digesting the salivary proteins with trypsin prior to separation via 
reverse-phase HPLC inline with the mass spectrometer. This variety of techniques 
worked in concert together to maximize the quality and quantity of useful information 
and cross-technique validations. 
2.4.2 Protein Quantification 
Quantification of Total Protein Concentration  
In addition to the discussion of quality handling of the saliva samples during 
collection, storage and processing, the quantification of protein concentration must be 
highlighted. The very first quantification of salivary protein concentration in any sample 
in this study was the measurement of total protein concentration. While numerous 
methods are available to achieve the quantification of total protein in a sample, saliva’s 
varied and complex composition, as well as the large normal range of total protein 
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concentration, narrows the selection of appropriate protein concentration assays. This 
work compared the results of two well-established protein quantification methods, the 
Bradford assay and the BCA assay. The most suitable protein quantification assays are 
those in which the properties being measured are equally distributed within all samples. 
The BCA assay’s detection of peptides bonds and four amino acids in salivary samples 
is much more representative of the total protein concentration than the less uniformly 
distributed hydrophobic and ionic interactions detected by the Bradford method. For this 
reason, the BCA assay was selected for this study. Ultimately, the basic salivary 
composition greatly guides the selection of the techniques and technologies applicable 
to its study. Once the total protein concentration of all the samples were achieved, the 
focus shifted to the accurate quantification of individual or subsets of proteins within 
saliva, such as those achieved with the quantification of protein profile bands in both 
SDS and anionic PAGE experiments. 
Quantification of PAGE Band Intensities 
 The quantification of bands from both types of PAGE (SDS and anionic) 
demonstrated clear visual relative quantitative representations of protein profiles for 
individuals in all four groups. Anionic PAGE revealed a striking difference in the protein 
profile of children with complete dental eruption (Group C), compared to the children 
with no dentition (Group A), children with partial dentition (Group B), and adults with no 
dentition (Group D) (Figures 2.3 and 2.4). The greatest difference is seen in the section 
of the gel with the same relative migration as the human serum albumin control. 
Albumin is a major salivary protein derived from serum exudate that enters the oral 
cavity at the interface between the teeth and gums through a source known as gingival 
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crevicular fluid (GCF). An increase in the number of teeth erupted produces a larger 
interface surface between the teeth and gums and therefore a larger the potential 
contribution of serum exudate components harbored in GCF.  
As expected, the group with the highest number of erupted teeth (Group C) has 
the highest concentration of potential HSA. The group with a fewer number of erupted 
teeth (Group B) has a notably lower concentration of potential albumin. Lastly, the two 
groups with no teeth (Groups A and D) have an even lower concentration of potential 
albumin. The relative protein quantification provided by the MS analyses (seen in Table 
2.6) are perfectly aligned with this trend of albumin concentration increasing as the 
number of teeth increase. These findings serve to highlight the importance of studying 
children throughout the course of dental eruption, as clear quantitative changes are 
detectable at different stages of development. These changes must be taken into 
account prior to development of standard baseline measurements of salivary protein 
profiles.  
The SDS PAGE also revealed a striking difference in the protein profile of 
children at different stages of dental eruption as well as the adult edentulous controls. 
Figures 2.6-2.9 suggest the degree of variation between individuals of the same group 
(intra-group variability) decreases with age. The greatest differences in the protein 
profiles are seen in the youngest children (Group A- approximate age 0-6 months), with 
increasingly more conformity to a single protein profile trend as the average age of the 
subjects increases (Groups B, C, and finally adults in Group D).  
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The inter-group variation summaries displayed in Figures 2.11 and 2.12 
illuminate the prominent differences in the average protein profiles of each of the four 
groups. While both figures summarize the same information, the data was acquired in 
two ways. Figure 2.11 summarizes data of an independent gel loaded with each lane 
representing a single group, while Figure 2.12 displays data of summed protein profiles 
from different gels (Figure 2.12). While similar conclusions can be drawn from both 
summaries, attention is drawn to Figure 2.11, as it provides a more direct comparison of 
the protein profiles run simultaneously. As seen in Figure 2.11, Group A (the youngest 
children in this study, representing the salivary proteome pre-dental eruption) appears 
to have a far greater abundance of large MW proteins (80 kDa or greater) relative to all 
the other groups. The relative protein quantification provided by the MS analyses (seen 
in Table 2.6) are also perfectly aligned with this observation. The relative abundance of 
mucin-5B precursor (596 kDa) is seen in much greater abundance in the youngest 
cohort (Group A), than in the other 3 groups. This may indicate a lower amount of 
proteolytic cleavage experienced in children with no dentition. In the absence of teeth, 
as is the case in Group A, the proteins that are known to adhere to the surface of teeth 
are not yet established in a stable or permanent way in the oral environment. With a 
decrease in the number of surfaces available for the adherence of proteolytic enzymes, 
it is expected to observe a lower concentration of these enzymes and their associated 
proteolytic activity. Related to the anionic PAGE results, the SDS PAGE results in 
Figure 2.11 displayed the greater abundance of protein at approximately 60 kDa in 
Group C relative to all the other groups. HSA, the most abundant protein in blood, has a 
known molecular weight of 67 kDa. As underscored previously in the discussion of the 
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anionic PAGE results, this striking difference of Group C relative to the other groups 
may be an indication a protein derived from GCF, as Group C is the only group with fully 
present dentition and therefore a maximum interface of teeth and gums (the entry point 
of GCF into saliva).  
While these results across PAGE platforms are promising, quantifications of 
protein profiles will be more useful once protein identities can be confidently assigned. 
To enhance the quality of comparison, and help control for variability between 
migrations of samples on different gels, an internal control of a single individual can be 
run consistently on all gels. 
2.4.3 Protein Separation 
As the resolution of separation is increased, an even greater wealth of 
information may be derived from the analysis. We were able to separate proteins in 
whole saliva based on molecular, negative charge and hydrophobicity. Additional 
separation may also be achieved using techniques such as positive charge or protein 
binding affinities to further develop the complete picture of the components of the 
salivary proteome at different ages. 
While often very time-consuming, method optimization with liquid 
chromatography provides very high-resolution separation on a multitude of dimensions, 
dependent on column and gradient selection. Chromatograms also allow for the 
potential of peak quantification if a panel of isolated proteins may be acquired to 
correlate the area under the curve with absorbance for each protein species.  
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2.4.4 Proteins Identified 
The MS analysis completed in this study resulted in the identification of fewer 
than 100 proteins (79 proteins) across all groups. The rather low number of protein 
identifications across the four groups could be expanded when greater sample volumes 
are collected and made available to repeat the MS runs more than the duplicates 
completed in this study. A greater number of runs would further increase the likelihood 
of identifying more lower abundance proteins. It is important to note that proteins 
present in lower abundance are often of greatest interest in diagnostic testing. A longer 
liquid chromatography separation method, from the 80 minutes described in this study 
to 2-4 hours, would enhance protein separation, and may result in an increase in the 
number of successful protein identification. 
Alternative pre-processing of the samples prior to loading on the inline HPLC 
may serve to further enhance the number and confidence of protein identifications. Due 
to the presence of high-abundance proteins (i.e. albumin, mucin, complement 
component proteins), immunodepletion may be used to help reveal proteins in lower 
abundance. Mucin is a good candidate to target with immunodepletion because of its 
great abundance in whole saliva, its large size (>500 kDa), and extensive glycosylation 
making it highly susceptible to aggregation. Immunodepletion, much like any purification 
or simplifying measure, may be associated with undesired effects, such as the 
elimination of other protein species through non-specific binding, or their close 
association with the targeted and eliminated protein.  The detection sensitivity and 
quantitation technologies that continue to advance in the MS field have the potential to 
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provide a more detailed assessment of differentially expressed proteins in saliva, 
especially if the complexity of the samples can be successfully managed. 
Even with the limited number of protein identifications, a number of interesting 
stories have come to light. For example, beta-casein, a member of a phosphoprotein 
family present in mammalian milk, was detected only in the youngest cohort (Group A – 
children from approximately 0-6 months of age). This finding helps to validate the 
techniques of sample collection and analysis, as children 0-6 months of age have a diet 
primarily composed of mammalian milk. 
The relative protein quantification trends provided by the MS analyses (seen in 
Table 2.6) serve as rough estimates of trends present in the salivary proteome. More 
replicates and greater number of identified peptides and spectra are required to draw 
definitive and absolute conclusions. This study describes relative abundance trends in 
specific proteins between groups. The relative abundance trends are extracted from 
Table 2.6 by comparing the total number of unqiue spectra counts for each protein in 
the different groups. As previously defined, unique spectrum counts is the term used to 
represent the number of one of a kind MS/MS fragmentation spectra that map to 
peptides of a given protein. The number of unqiue spectrum counts may be greater than 
the number of unique peptide counts due to the presence of variable modifications, 
such as oxidation of methionine. The same unique peptide may be counted as multiple 
unique spectra if the variable modifications are present in one spectra, but not in 
another. Spectral counting offers a means of comparing protein abundance across 
groups, if the same preparation and isolation techniques were applied for each 
experiment. 
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There are critical considerations to keep in mind when using abundance 
comparisons obtained through spectral counting. The first major consideration to 
highlight is the appropriate use of inter-group comparisons of a given protein, rather 
than inter-protein comparisons even within the same group, which are not reliable. 
Abundance comparisons through spectral counting does not allow for a proper 
comparison of different proteins and their relative abundance. This is due to technical 
considerations of MS-based approaches that depend on the efficiency of protein 
digestion (related to size, and number of lysine and arginine residues, etc.), the 
ionization efficiency, and the quality of HPLC separation (i.e. presence of co-elution). It 
is for this reason that the rank order of the top 15 quantified proteins is not emphasized 
significantly, but rather the focus is given to the relative abundance of a single protein 
between different groups. Comparing the relative abundance of one protein with another 
even within the same group requires careful attention and validation, due to the points 
mentioned above. The quality of HPLC separation, and presence of co-elutioning 
proteins is also a point of consideration for valid inter-group comparisons of a given 
protein, as the variable composition of samples between groups can serve to mask a 
protein in some groups but not equally in others. 
Despite the issues associated with reliability of protein abundance comparison, 
spectral counting provides a reasonable estimation method for ball-park global 
quantification of abundant proteins. The results that were achieved in this study serve 
as a good reference point from which to continue exploring. The following paragraphs 
highlight the most significant findings in abundance trends, as determined by the 
quantification of unique peptide and spectrum counts. The use of unqiue ion counts is 
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another very valid route to describe these findings, and is preferred by some 
researchers. For the purpose of this analysis and as is often the case, both 
measurements result in the same relative rank order of the top most abundant identified 
proteins, and resultant abundance trends. The cut-off determined for categorizing the 
top 15 proteins (as displayed in Figure 2.6) was determined by the minimum unique 
peptide count set at 2, if a peptide was detected at all. 
Amylase (56 kDa) was found to be in lowest abundance in the adult controls 
(Group D), relative to all the child cohorts (Groups A, B, and C). The highest abundance 
of amylase was observed in children post dental eruption (Group C). This could reflect 
the requirement of higher amylase concentrations in individuals with complete dentition, 
as amylase functions to prevent bacterial attachment to the tooth surface and assist in 
bacterial clearance.    
Albumin’s (69 kDa) relative abundance trend serves as an excellent example of 
cross-technique validation in this study. The relative MS quantification of albumin 
validates the findings from the anionic gels, as the relative abundance of albumin 
increases as the number of erupted teeth increases. Albumin’s abundance is nearly 2-
fold greater in children with all of their primary dentition (Group C), relative to children 
pre-dental eruption (Group A). The relative abundance of albumin in Group B (children 
during dental eruption) is between that of Group A and Group C, as to be expected if 
the albumin concentration is related to the potential GCF contribution in children with 
teeth versus children without any teeth. 
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Lactoperoxidase isoform 1 preproprotein (80 kDa) was detected in the youngest 
group (Group A) with approximately a two-fold greater abundance than in all the other 
groups (Groups B, C, and D). The presence of this lactoperoxidase precursor molecule 
in saliva is not a surprise, as lactoperoxidase is a well-known endogenous salivary 
protein produced by the salivary glands. Lactoperoxidase is one of the two major 
peroxidases in whole saliva, along with myeloperoxidase, functioning primarily as an 
anti-bacterial agent. The heighten abundance of this innate immune molecule in the 
youngest group (Group A) is again well inline with the large innate immune response in 
infants, that compensates for their weaker adaptive immune system which is not fully 
developed in the first few months of life.   
As previously mentioned, the relative abundance of mucin (mucin-5B precursor, 
and mucin 7) is highest in children pre-dental eruption (Group A), relative to all the other 
groups, as suggested and described in the SDS-PAGE results. 
Von Ebner’s gland protein (19 kDa) was detected in all the children groups 
(Group A, B, and C), but not in the edentulous adult controls (Group D). This finding has 
not previously been documented. 
The following proteins were not seen to change dramatically between the four 
groups: Carbonic anhydrase VI (35 kDa), Prolactin Inducible Protein, unnamed protein 
products with a MW of 53 kDa and 19 kDa, and a hypothetical protein of 38 kDa. The 
unnamed protein products and hypothetical protein are good candidates for further 
interaction studies, as very little is known about them and their functions in whole saliva. 
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To enable the further relative and absolute quantitative measurements of salivary 
proteins in different groups, proteins may be labeled prior to separation and mass 
spectrometry. Protein labeling (iTRAQ) was attempted during the course of this work but 
required more biological samples than were presently available from the collection from 
all individuals to return meaningful results. Through the combination of immunodepletion 
to increase the probability of low abundance protein identification, as well as protein 
labeling, more meaningful quantitative results of a panel of salivary proteins may be 
achieved. 
2.4.5 Future Work 
The motivation for identifying and understanding the changes in the salivary 
proteome for all ages in health or pathology is to lay the groundwork for the 
development of diagnostic tools to assess the physiological state of individuals through 
non-invasive salivary testing. Understanding the differences in salivary proteins and the 
salivary proteome present throughout life in health and disease is a necessity to 
accurately identify salivary protein-drug interactions, to accurately measure salivary 
drug concentrations and identify disease markers in saliva. 
The advancement of useful clinical tools must be firmly planted in an 
understanding of the biochemistry of saliva and the ways in which composition is altered 
with age, states of health and presence or absence of drugs. The work with 
unstimulated saliva from healthy individuals, such as that of this research, is truly the 
foundation that must be set before the study of the changes in composition of the 
salivary proteome can be expanded to include diseased states and drug-induced 
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changes in salivary biochemistry. The recognition of a drugs ability to alter the salivary 
proteome is of tremendous importance, especially in the development of drug-specific 
assays for the monitoring of drug concentrations in saliva.  
Some of the most helpful advances in salivary research are those that bring to 
light the often unmentioned considerations that are critical to producing reproducible 
and meaningful results. This study encourages future work to be mindful of the careful 
monitoring of salivary sample collection, storage and processing techniques. Future 
work must recognize the importance of careful selection of individuals free of 
medications, as this is imperative at this stage of analysis. Many drugs are able to 
interfere with the process of salivary secretion, as well as binding salivary proteins. 
Much attention is needed to elucidate the drug-associated changes in the salivary 
proteome, once a healthy baseline is confidently identified at different ages and states. 
To achieve this aim, future work is needed with a  focus on the determination of 
protein identities separated with PAGE and liquid chromatography. The use of mass 
spectrometric identification of proteins can allow us to better elucidate differences,  
specifically in young children who have been seen here to have notably unique salivary 
protein profiles as compared not only with adult controls, but also between 
developmental stages in children as dental eruption events unfold.  
We must remain conscious of the developmental stage of an individual as we 
work towards future diagnostic test development. As seen in this study, age plays a 
noticeable role in the salivary protein profile. This age-specific focus on protein profiling 
needs to be continued to provide a higher resolution image of the dynamic changes in 
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the salivary proteome. In future studies, the close monitoring of the age and 
developmental stage (i.e. pre- or post-dental eruption) of an individual will be very useful 
to account for and limit the variation of the protein profile related to age. More replicates 
are needed to draw definitive conclusions on the relative and absolute quantified 
changes in the salivary proteome. A greater sample size (n > 48 per group), as 
determined by this study, and larger sample volumes will serve to increase the amount 
of testing possible, and as a result, increasing the quantity of findings and confidence in 
future studies. 
Once a more comprehensive description of the changing salivary proteome in 
healthy children is achieved, protein profiles of children with specific pathologies may be 
compared to identify presence of any distinguishing salivary protein markers. The 
greater degree of protein profile variability observed in this study in children 0-6 months 
of age, relative to children 6 months-3 years of age, as well as adult controls, will 
hopefully stir further excitement and enthusiasm in the efforts focused on uncovering of 
the complexities of the dynamic nature of the salivary proteome in the youngest of 
children. It is this youngest cohort that may benefit the most from repeated non-invasive 
and pain-free salivary diagnostics to inform clinical decisions. With a better 
understanding, salivary protein markers may then be further explored for relevance in 
diagnostic, prognostic and/or condition/treatment monitoring tests. This will provide 
insights into the potential use of salivary drug concentrations for therapeutic drug 
monitoring in children. 
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By addressing the limitations of this present research, future efforts can build on 
this knowledge and continue to move the field of salivary biochemistry, and ultimately 
salivary diagnostics in children, forward and into the medical and dental clinics. 
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Appendix 3 
Results 
Table A3.1 - Clinical data summary – Inter-group Age Comparison 
Clinical Data Inter-group Age Comparison 
AGE 
 Group A Group B Group C Group D 
Age Standard Age Standard Age Standard Age Standard 
  (months) Error (months) Error (months) Error (months) Error 
N 12  10  12  10  
Mean 4.667 0.583 14.200 1.777 34.167 1.661 597.491 33.490 
95% CI for Mean         
Lower Bound 3.383  10.180  37.822  521.731  
Upper Bound 5.951  18.220  30.511  673.251  
5% Trimmed Mean 4.755  14.153  37.822  599.379  
Median 5.125  14.625  34.324  612.480  
Variance 4.083  31.581  33.625  11215.852  
Standard Deviation 2.021  5.620  5.754  105.905  
Minimum 0.750  6.250  23.500  420.000  
Maximum 7.000  23.000  42.000  741.000  
Range 6.250  16.750  18.500  321.000  
Interquartile Range 3.750  10.440  9.440  167.260  
Skewness -0.600 0.637 -0.052  -0.230 0.637 -0.479 0.687 
Kurtosis -0.737 1.232 0.942   -0.773 1.232 -0.728 1.334 
 
Table A3.2 - Clinical data summary – Inter-group Total Protein Comparison 
Clinical Data Inter-group Total Protein Comparison 
TOTAL PROTEIN CONCENTRATION 
  Group A Group B Group C Group D 
 Total  Total  Total  Total  
 protein Standard protein Standard protein Standard protein Standard 
  (µg/mL) Error (µg/mL) Error (µg/mL) Error (µg/mL) Error 
N 12.0  10.0  12.0  10.0  
Mean 699.4 119.5 921.4 262.9 1019.2 83.1 1655.0 454.6 
95% CI for Mean         
Lower Bound 436.3  326.7  836.4  672.0  
Upper Bound 962.4  1516.0  1202.0  2638.0  
5% Trimmed Mean 670.7  826.3  1022.5  1493.0  
Median 553.5  697.1  980.1  1287.5  
Standard Deviation 414.0  831.2  287.7  1374.2  
Minimum 235.5  346.7  495.6  826.9  
Maximum 1679.3  3207.3  1484.2  5398.9  
Range 1443.8  2860.6  988.6  4572.0  
Interquartile Range 467.1  509.2  471.9  854.5  
Skewness 1.3 0.6 2.8 0.7 0.0 0.6 2.7 0.7 
Kurtosis 1.8 1.2 8.2 1.3 -0.5 1.2 7.8 1.3 
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Table A3.3 - Clinical data summary – Inter-group Volume of Saliva Comparison 
Clinical Data Inter-group Volume of Saliva Comparison 
VOLUME OF SALIVA 
  Group A Group B Group C Group D 
Volume of Standard Volume of Standard Volume of Standard Volume of Standard 
 
 Saliva (mL) Error  Saliva (mL) Error  Saliva (mL) Error  Saliva (mL) Error 
N 12  10  12  10  
Mean 0.404 0.057 0.300 0.060 0.371 0.049 1.280 0.335 
95% CI for Mean         
Lower Bound 0.280  0.165  0.262  0.523  
Upper Bound 0.529  0.435  0.480  2.037  
5% Trimmed Mean 0.402  0.294  0.373  1.244  
Median 0.450  0.250  0.450  1.000  
Variance 0.038  0.036  0.029  1.120  
Standard Deviation 0.196  0.189  0.171  1.058  
Minimum 0.050  0.100  0.100  0.200  
Maximum 0.800  0.600  0.600  3.000  
Range 0.750  0.500  0.500  2.800  
Interquartile Range 0.280  0.400  0.300  2.080  
Skewness 0.056 0.637 0.373 0.687 -0.394 0.637 0.441 0.687 
Kurtosis 0.703 1.232 -1.508 1.334 -1.530 1.232 -1.481 1.334 
 
Table A3.4 - Clinical data summary – Inter-group Number of Teeth Erupted Comparison 
Clinical Data Number of Teeth Erupted 
TEETH ERUPTED 
  Group A Group B Group C Group D 
 
Teeth Erupted 
(#) 
Teeth Erupted 
(#) 
Standard 
Error 
Teeth Erupted 
(#) 
Teeth Erupted 
(#) 
N 12 10  12 10 
Mean 0 8 1.74483 20 0 
95% CI for Mean      
Lower Bound N/A 4.0529  N/A N/A 
Upper Bound N/A 11.9471  N/A N/A 
5% Trimmed Mean N/A 7.9444  N/A N/A 
Median N/A 6.5  N/A N/A 
Variance N/A 30.444  N/A N/A 
Standard Deviation N/A 5.51765  N/A N/A 
Minimum N/A 1  N/A N/A 
Maximum N/A 16  N/A N/A 
Range N/A 15  N/A N/A 
Interquartile Range N/A 11  N/A N/A 
Skewness N/A 0.496 0.687 N/A N/A 
Kurtosis N/A -1.166 1.334 N/A N/A 
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Table A3.5 - Nonparametric Correlations - Age and Protein Concentration 
Spearman's rho 
  
    
Age Protein Concentration 
Age Correlation Coefficient 1 0.48** 
 Significance (2-tailed)  0.001 
 N 44 44 
Protein Concentration Correlation Coefficient 0.48** 1 
 Significance (2-tailed) 0.001  
  N 44 44 
** Correlation is significant at the level of 0.01 (2-tailed)  
 
Table A3.6 - Nonparametric Correlations – Protein Concentration and Age in Females 
Spearman's rho 
  
    
Protein 
Concentration Age 
Protein Concentration Correlation Coefficient 1 0.635** 
 Significance (2-tailed)  0.005 
 N 18 18 
Age Correlation Coefficient 0.635** 1 
 Significance (2-tailed) 0.005  
  N 18 18 
** Correlation is significant at the level of 0.01 (2-tailed)  
 
Table A3.7 - Nonparametric Correlations - Protein Concentration and Age in Males 
Spearman's rho 
  
    
Protein 
Concentration Age 
Protein Concentration Correlation Coefficient 1 0.42** 
 Significance (2-tailed)  0.033 
 N 26 26 
Age Correlation Coefficient 0.42** 1 
 Significance (2-tailed) 0.033  
  N 26 26 
** Correlation is significant at the level of 0.05 (2-tailed)  
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Table A3.8 - Nonparametric Correlations – Volume of Saliva and Protein Concentration 
Spearman's rho 
  
    
Volume of 
Saliva 
Protein 
Concentration 
Volume of Saliva Correlation Coefficient 1 0.066 
 Significance (2-tailed)  0.672 
 N 44 44 
Protein Concentration Correlation Coefficient 0.066 1 
 Significance (2-tailed) 0.672  
  N 44 44 
  
Table A3.9 - Nonparametric Correlations – Age and Volume of Saliva 
Spearman's rho 
  
    
Age Volume of Saliva 
Age Correlation Coefficient 1 0.252 
 Significance (2-tailed)  0.098 
 N 44 44 
Volume of Saliva Correlation Coefficient 0.252 1 
 Significance (2-tailed) 0.098  
  N 44 44 
  
Table A3.10 - Nonparametric Correlations – Protein Concentration and Teeth Erupted 
Spearman's rho 
  
    
Protein 
Concentration Teeth Erupted 
Protein Concentration Correlation Coefficient 1 0.067 
 Significance (2-tailed)  0.668 
 N 44 44 
Teeth Erupted Correlation Coefficient 0.067 1 
 Significance (2-tailed) 0.668  
  N 44 44 
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Table A3.11 - Nonparametric Correlations – Protein Concentration and Teeth Erupted in 
Females 
Spearman's rho 
  
    
Protein 
Concentration Teeth Erupted 
Protein Concentration Correlation Coefficient 1 0.184 
 Significance (2-tailed)  0.464 
 N 18 18 
Teeth Erupted Correlation Coefficient 0.184 1 
 Significance (2-tailed) 0.464  
  N 18 18 
  
 
Table A3.12 - Nonparametric Correlations – Protein Concentration and Teeth Erupted in 
Males 
Spearman's rho 
  
    
Protein 
Concentration Teeth Erupted 
Protein Concentration Correlation Coefficient 1 -0.021 
 Significance (2-tailed)  0.918 
 N 26 26 
Teeth Erupted Correlation Coefficient -0.021 1 
 Significance (2-tailed) 0.918  
  N 26 26 
  
  
Table A3.13 - Nonparametric Tests – Hypothesis Test Summary – Kruskal-Wallis 
Hypothesis Test Summary 
  Null Hypothesis Test Significance Decision 
1 The distribution of Age is the same 
across all Groups Independent-Samples Kruskal-Wallis Test 0 Reject the null hypothesis 
2 The distribution of Protein Concentration is the same across all groups  Independent-Samples Kruskal-Wallis Test 0.598 Retain the null hypothesis 
3 The distribution of Volume of Saliva is the 
same across all Groups Independent-Samples Kruskal-Wallis Test 0.266 Retain the null hypothesis 
4 The distribution of Teeth Erupted is the 
same across all Groups Independent-Samples Kruskal-Wallis Test 0 Reject the null hypothesis 
Asymptotic significances are displayed. The significant level is 0.05. 
 
 
Table A3.14 - Nonparametric Tests – Hypothesis Test Summary – Mann-Whitney U 
Hypothesis Test Summary 
  Null Hypothesis Test Significance Decision 
1 The distribution of Age is the same 
across all Groups Independent-Samples Mann-Whitney U Test 0 Reject the null hypothesis 
2 The distribution of Protein Concentration is the same across all groups  Independent-Samples Mann-Whitney U Test 0.024 Reject the null hypothesis 
3 The distribution of Volume of Saliva is the 
same across all Groups Independent-Samples Mann-Whitney U Test 0.81 Retain the null hypothesis 
4 The distribution of Teeth Erupted is the 
same across all Groups Independent-Samples Mann-Whitney U Test 0 Reject the null hypothesis 
Asymptotic significances are displayed. The significant level is 0.05. 
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Appendix 4 
Results – HSA Area under the curve of chromatograms 
25ug BSA stnd from BCA kit
Time
36.00 38.00 40.00 42.00 44.00
AU
0.0
5.0e-5
36.00 38.00 40.00 42.00 44.00
AU
0.0
5.0e-5
36.00 38.00 40.00 42.00 44.00
AU
0.0
2.0e-5
4.0e-5
08032011 sample 21 Diode Array 
280
Range: 3.8e-5
40.58
4871
40.42
485138.72
4647
37.50
4501 43.67;5242
08032011 sample 20 Diode Array 
280
Range: 6.0e-5
40.47
4858
40.08
4810
37.67
4521
37.15
4459
40.58
4871
42.49;5100
08032011 sample 19 Diode Array 
280
Range: 6.3e-5
40.38
4847
39.80;4777
36.12
4335
41.14
4938
43.80
5257
  
10ug BSA stnd from BCA kit
Time
36.00 38.00 40.00 42.00 44.00
AU
0.0
5.0e-5
36.00 38.00 40.00 42.00 44.00
AU
0.0
5.0e-5
36.00 38.00 40.00 42.00 44.00
AU
0.0
5.0e-5
08032011 sample 18 Diode Array 
280
Range: 6.5e-5
40.59
4872
39.59;475236.754411
41.19
4944
43.72;5248
08032011 sample 17 Diode Array 
280
Range: 7.6e-5
40.65
4879
37.20
4465
38.77
4653
41.18
4943
43.91
5270
08032011 sample 16 Diode Array 
280
Range: 8.0e-5
40.62
4875
39.56
4748
38.82
4659
37.62
4515
41.17
4942
42.73;5129
 
5ug BSA stnd from BCA kit
Time
36.00 38.00 40.00 42.00 44.00
AU
0.0
5.0e-5
36.00 38.00 40.00 42.00 44.00
AU
0.0
5.0e-5
36.00 38.00 40.00 42.00 44.00
AU
0.0
5.0e-5
08032011 sample 15 Diode Array 
280
Range: 4.9e-5
40.52
486338.52
4623
37.02
4443
41.15
4939
42.72;5128
08032011 sample 14 Diode Array 
280
Range: 8.2e-5
40.62
4875
40.12;481537.174462
40.85
4903
42.72;5128
08032011 sample 13 Diode Array 
280
Range: 5.7e-5
40.59
4872
40.21;482637.52
4503
41.15
4939 42.73;5129
 
2.5ug BSA stnd from BCA kit
Time
36.00 38.00 40.00 42.00 44.00
AU
0.0
5.0e-5
36.00 38.00 40.00 42.00 44.00
AU
0.0
5.0e-5
36.00 38.00 40.00 42.00 44.00
AU
0.0
5.0e-5
08032011 sample 12 Diode Array 
280
Range: 5.1e-540.554867
40.17;482237.044446
41.09
4932 42.18;5063
08032011 sample 11 Diode Array 
280
Range: 8.3e-5
40.58
4870
36.53
4385
37.13
4457 39.20
4705
40.88
4906 42.48;5099
08032011 sample 10 Diode Array 
280
Range: 7.6e-5
40.58
487036.14
4338 39.58
4751
37.78
4535
41.12
4935
42.54;5106
  
1.25ug BSA stnd from BCA kit
Time
36.00 38.00 40.00 42.00 44.00
AU
0.0
5.0e-5
36.00 38.00 40.00 42.00 44.00
AU
0.0
5.0e-5
36.00 38.00 40.00 42.00 44.00
AU
0.0
5.0e-5
08032011 sample 9 Diode Array 
280
Range: 7.8e-540.63487740.46485636.14
4338 39.30;4717 42.51;5102
08032011 sample 8 Diode Array 
280
Range: 6.8e-5
40.59
487238.78
4655
37.73
4529
41.43
4973
43.74
5250
08032011 sample 7 Diode Array 
280
Range: 4.9e-5
40.88
490640.56
4868
39.03
468536.63
4396
41.44
4974
43.88
5266
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Appendix 5 
Results – Unstimulated whole saliva chromatograms
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Appendix 6 
 
Details of calculation for future sample size recommendation for comparison using two 
independent means as mentioned in Section 2.2.3 and described by Altman DG, 
Machin D, Bryant TN, Gardner MJ. Statistics with confidence, 2nd edition. BMJ Books, 
2000. 
n = 2 * (Z1-α/2 + Z1-β)2 * σ2 / ∆2 
n = 2 * (1.96 + 0.84)2 * 3502 / 2002 
n = 2 * 7.84 * 122,500 / 40,000 
n = 48.02 or 48 per group 
Conclusion: 48 subjects are needed in each group to have an 80% chance of detecting 
a clinically meaningful difference in total protein concentration of 200 ug/mL between 
groups, assuming an alpha of 0.05, and a standard deviation of 350 ug/mL.  
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